Antigen Information
General Information of This Antigen
| Antigen ID | TAR0FPXYP |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | Undisclosed |
|||||
| Gene Name | Undisclosed |
|||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
14B6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-04 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
14C4
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-05 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-14 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
17C2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-06 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
1D11
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
jP2024501894A5-8 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
jP2024501894A5-16 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
jP2024501894A5-18 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] | |
jP2024501894A5-19 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] |
23C2 Her2-2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
eP4183421A1 23C2 Her2-2-DXD |
Exatecan |
Undisclosed |
EP4183421A1+Trastuzumab-DXD+Linker |
[3] | |
eP4183421A1 23C2 Her2-2-DDDXD |
Exatecan |
Undisclosed |
EP4183421A1+Trastuzumab-DDDXD+Linker |
[3] | |
cN114569739A 23C2 Her2-2-DXD |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-1 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-2 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-3 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-4 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-5 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-6 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-7 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] | |
cN114569739A ADC-8 (23C2 Her2-2) |
Undisclosed |
Undisclosed |
Undisclosed |
[4] |
345A12-14AAS
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
cN119630431A ADC-9 |
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
Undisclosed |
[5] | |
cN119630431A ADC-10 |
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
CN119630431A-ADC-3-LINKER |
[5] | |
cN119630431A ADC-11 |
CN119630431A-ADC-1-PAYLOAD |
Undisclosed |
CN119630431A-ADC-5-LINKER |
[5] |
45-2D9
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Monoclonal antibody 45-2D9-haematoporphyrin conjugate |
Hematoporphyrin |
Undisclosed |
Undisclosed |
[6] |
5A8
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-01 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
7B12
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-02 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-12 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
7D12-fGly
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
39138197 7D12-fGly MNB-Pyra |
MNB-Pyra |
Undisclosed |
Undisclosed |
[7] |
9D10
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-03 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-13 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-20 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-22 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-24 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
a therapeutic human IgG4 mAb
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
40037092 ADC-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[8] | |
40037092 ADC-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[8] |
Ab-2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
39757732 ADC1 |
Monomethyl auristatin E |
Undisclosed |
D1 Linker |
[9] | |
39757732 ADC2 |
PBD dimer |
Undisclosed |
D2 Linker |
[9] | |
39757732 ADC3 |
Monomethyl auristatin E |
Undisclosed |
D3 Linker |
[9] | |
39757732 ADC4 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
D4 Linker |
[9] |
ABT-700
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-10 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
WO2024131835A1 ADC-18 (ABBV-399
analogue) |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
AHK
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AHK-PABC-Exa |
Exatecan |
Undisclosed |
Mc-Val-Cit-PABC |
[10] |
Anti-B-cell mAb SN7
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Monoclonal antibody SN7-ricin chain A conjugate |
Deglycosylated ricin A-chain (dgA) |
Undisclosed |
Undisclosed |
[11] |
Anti-mAb303
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
TW202444426A ADC-301 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-043-A |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-043-B |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-302 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-045-A |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-046-B |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-303 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] |
Anti-mAb304
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
TW202444426A ADC-031 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-310-A |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-311-B |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-032 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-312-A |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-313-B |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-033 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-034 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] |
Anti-mAb305
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
TW202444426A ADC-027 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-028 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-304 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-305-A |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-306-B |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-307 |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-308-A |
Undisclosed |
Undisclosed |
Undisclosed |
[12] | |
TW202444426A ADC-309-B |
Undisclosed |
Undisclosed |
Undisclosed |
[12] |
anti-mPD-L1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-46 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] |
Anti-TPP-5442
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
US12144865B2 31t-4 |
Undisclosed |
Undisclosed |
Undisclosed |
[14] | |
US12144865B2 34t-4 |
Undisclosed |
Undisclosed |
Undisclosed |
[14] |
Anti-TPP-7511
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
US12144865B2 34te-4 |
Undisclosed |
Undisclosed |
Undisclosed |
[14] |
ARKRA
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
ARKRA-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
Azido Modified XMT-1604
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
jP2024501894A5-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[2] |
B12
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-11 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-19 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
uS20230285580A1 B12-B1 |
B4 Payload |
Deoxyribonucleic acid (DNA) |
US20230285580A1 B12-B2 linker |
[15] | |
uS20230285580A1 B12-B2 |
US20230285580A1 B12-B3 payload |
Undisclosed |
US20230285580A1 B12-B2 linker |
[15] | |
uS20230285580A1 B12-B3 |
US20230285580A1 B12-B3 payload |
Undisclosed |
US20230285580A1 B12-B6 linker |
[15] | |
uS20230285580A1 B12-B4 |
US20230285580A1 B12-B4 payload |
Undisclosed |
US20230285580A1 B12-B6 linker |
[15] | |
uS20230285580A1 B12-B6 |
B4 Payload |
Deoxyribonucleic acid (DNA) |
US20230285580A1 B12-B6 linker |
[15] |
CA1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CA1-vedotin |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[16] |
CANO01
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
cANO01-MC-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimidocaproyl (me) linker |
[17] |
CEA.5GlfhL2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-51 |
AU2020291014A1-Payload-49 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-57 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] |
CEA.9-G1fhL2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-81 |
AU2020291014A1-Payload-77 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-82 |
AU2020291014A1-Payload-72 |
Undisclosed |
Aminobenzazepine-linker Formula II-72 |
[13] | |
AU2020291014A1 IC-83 |
AU2020291014A1-Payload-74 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-84 |
AU2020291014A1-Payload-80 |
Undisclosed |
Aminobenzazepine-linker Formula II-80 |
[13] |
CEA.9-GlfhL2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-67 |
AU2020291014A1-Payload-41 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-68 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-69 |
AU2020291014A1-Payload-69 |
Undisclosed |
Aminobenzazepine-linker Formula II-69 |
[13] |
control mouse IgG
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Nonbinding control-ADC |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[18] |
Control mouse IgG
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Non-binding IgG -ADC |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[19] |
Goat anti-mouse IgG
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IgG-p (HEMA-co-MPS) |
p (HEMA-co-MPS) |
Undisclosed |
HEMA linker |
[20] |
H1H21234N
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
H1H21234N-compound 25 |
Undisclosed |
Undisclosed |
Undisclosed |
[21] |
H1H6958N2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
h1H6958N2-N297Q-Ex23 4 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
h1H6958N2-N297Q-Ex22 4 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
h1H6958N2-N297Q-Ex19 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
h1H6958N2-N297Q-Ex20 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
h1H6958N2-N297Q-Ex23 3.9 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
h1H6958N2-N297Q-Ex22 3.9 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] | |
h1H6958N2-N297Q-Ex24 |
Undisclosed |
Undisclosed |
Undisclosed |
[22] |
hIgG1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
hIgG1-MMAE (gylcan conjugation) |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[23] | |
hIgG1-MMAE (Lysine conjugation) |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[23] | |
CN116916962A-ADC-B14 |
Compound I-5c |
Undisclosed |
CN116916962A-C-18-linker |
[24] | |
CN116916962A-ADC-B15 |
Compound I-5c |
Undisclosed |
CN116916962A-C-30-linker |
[24] | |
CN116916962A-ADC-B16 |
Compound I-5c |
Undisclosed |
CN116916962A-C-41-linker |
[24] | |
CN116916962A-ADC-B17 |
Compound No.14 |
Undisclosed |
CN116916962A-C-38-linker |
[24] | |
CN116916962A-ADC-B18 |
Compound I-5c |
Undisclosed |
CN116916962A-C-18-linker |
[24] | |
CN116916962A-ADC-B19 |
Compound I-5c |
Undisclosed |
CN116916962A-C-39-linker |
[24] | |
CN116916962A-ADC-B20 |
Compound No.14 |
Undisclosed |
CN116916962A-C-38-linker |
[24] |
HK
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HK-PABC-Exa |
Exatecan |
Undisclosed |
Mc-Val-Cit-PABC |
[10] |
HKA
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
HKA-PABC-Exa |
Exatecan |
Undisclosed |
Mc-Val-Cit-PABC |
[10] |
HS627
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024140449A1 ADC1 |
WO2024140449A1+ADC1+payload |
Undisclosed |
Mc-Val-Cit |
[25] | |
wO2024140449A1 ADC3 |
WO2024140449A1+ADC1+payload |
Undisclosed |
WO2024140449A1+ADC3+Linker |
[25] | |
wO2024140449A1 ADC5 |
WO2024140449A1+ADC5+payload |
DNA topoisomerase I (TOP1) |
WO2024140449A1+ADC5+Linker |
[25] | |
wO2024140449A1 ADC7 |
WO2024140449A1+ADC5+payload |
DNA topoisomerase I (TOP1) |
WO2024140449A1+ADC7+Linker |
[25] | |
wO2024140449A1 ADC9 |
WO2024140449A1+ADC5+payload |
DNA topoisomerase I (TOP1) |
WO2024140449A1+ADC9+Linker |
[25] | |
wO2024140449A1 ADC11 |
WO2024140449A1+ADC5+payload |
DNA topoisomerase I (TOP1) |
WO2024140449A1+ADC9+Linker |
[25] | |
wO2024140449A1 ADC13 |
WO2024140449A1+ADC13+payload |
Undisclosed |
WO2024140449A1+ADC13+Linker |
[25] | |
wO2024140449A1 ADC15 |
WO2024140449A1+ADC13+payload |
Undisclosed |
WO2024140449A1+ADC13+Linker |
[25] | |
wO2024140449A1 ADC17 |
WO2024140449A1+ADC17+payload |
Undisclosed |
WO2024140449A1+ADC17+Linker |
[25] | |
wO2024140449A1 ADC19 |
WO2024140449A1+ADC19+payload |
Undisclosed |
WO2024140449A1+ADC19+Linker |
[25] | |
wO2024140449A1 ADC21 |
WO2024140449A1+ADC5+payload |
DNA topoisomerase I (TOP1) |
WO2024140449A1+ADC5+Linker |
[25] | |
cN117159739A ADC3 |
undisclosed |
Undisclosed |
Undisclosed |
[26] | |
cN117159739A ADC4 |
undisclosed |
Undisclosed |
Undisclosed |
[26] | |
cN117159739A ADC6 |
undisclosed |
Undisclosed |
Undisclosed |
[26] |
Hu1084
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
hu1084-MMAE-DAR3 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[27] | |
hu1084-MMAE-DAR8 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[27] | |
hu1084-DXd-DAR3 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[27] | |
hu1084-DXd-DAR8 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[27] |
hu2H11_R35-74
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
uS11998611B2 ADC1 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 ADC3 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.3 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.6 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.16 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.19 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.23 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.26 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.29 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] | |
uS11998611B2 Ex.32 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] |
hu2H11_R35-75
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
uS11998611B2 ADC2 |
Undisclosed |
Undisclosed |
Undisclosed |
[28] |
hu5B1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
hu5B1-TCO |
Undisclosed |
Undisclosed |
Undisclosed |
huCDCP1 (F30-T667 Q525)-8xHis_T3
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
aU2023308528A1 ADC4 |
Exatecan |
Undisclosed |
Mal-amido-PEG8-acid |
[29] | |
aU2023308528A1 mAb-vcMMAE (DAR of 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[29] | |
aU2023308528A1 ADC3 (DAR of 8) |
Exatecan |
Undisclosed |
Mal-amido-PEG8-acid |
[29] |
HuSS1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
eP4161582A4 Compound 3 |
EP4161582A4+Compound 3+payload |
Undisclosed |
EP4161582A4+Compound 3+Linker |
[30] | |
dBCO-vc-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
EP4161582A4+DBCO-vc-MMAE+Linker |
[30] | |
dBCO-S-DM1 |
Mertansine DM1 |
Undisclosed |
DBCO-PEG3-amine |
[30] | |
dBCO-vc-seco DUBA |
seco-DUBA |
Undisclosed |
EP4161582A4+DBCO-vc-seco DUBA+Linker |
[30] | |
dBCO-DTPA |
seco-DUBA |
Undisclosed |
EP4161582A4+DBCO-DTPA+Linker |
[30] | |
dBCO-PEG3-vc-Exatecan |
Exatecan |
Undisclosed |
DBCO-PEG3 linker |
[30] | |
dBCO-PEG3-GGFG-Exatecan |
Exatecan |
Undisclosed |
EP4161582A4+DBCO-PEG3-GGFG-Exatecan+Linker |
[30] | |
dBCO-PEG12-GGFG-Exatecan |
Exatecan |
Undisclosed |
EP4161582A4+DBCO-PEG12-GGFG-Exatecan+Linker |
[30] | |
dBCO-PEG3-GGFG-DXd2 |
EP4161582A4+DBCO-PEG3-GGFG-DXd2+payload |
Undisclosed |
DBCO-PEG3 linker |
[30] | |
dBCO-PEG12-GGFG-DXd2 |
EP4161582A4+DBCO-PEG12-GGFG-DXd2+payload |
Undisclosed |
EP4161582A4+DBCO-PEG12-GGFG-DXd2+Linker |
[30] | |
bCN-PEG3-VC-PAB-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
EP4161582A4+BCN-PEG3-VC-PAB-MMAE+Linker |
[30] | |
bCN-PEG12-GGFG-Exatecan |
Exatecan |
Undisclosed |
EP4161582A4+BCN-PEG12-GGFG-Exatecan +Linker |
[30] | |
bCN-PEG12-GGFG-DXd2 |
EP4161582A4+BCN-PEG12-GGFG-DXd2 +Linker |
Undisclosed |
EP4161582A4+BCN-PEG12-GGFG-DXd2 +Linker |
[30] | |
dBCO-PEG3-2 (PEG3-VC-PAB-MMAE) |
Monomethyl auristatin E |
Microtubule (MT) |
EP4161582A4+DBCO-PEG3-2 (PEG3-VC-PAB-MMAE)+Linker |
[30] | |
dCBPR2002-4 (DBCO-vc-MMAE) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-S-DM1) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-vc-seco DUBA) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG4-vc-PAB-MMAF) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-DTPA) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG3-vc-Exatecan ) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG3-GGFG-Exatecan) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG12-GGFG-Exatecan) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG3-GGFG-DXd2) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG12-GGFG-DXd2) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (BCN-PEG3-VC-PAB-MMAE) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (BCN-PEG12-GGFG-Exatecan) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (BCN-PEG3-GGFG-Exatecan) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (BCN-PEG12-GGFG-DXd2) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-4 (DBCO-PEG3-2 (PEG3-VC-PAB-MMAE)) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-2 (DBCO-vc-MMAE)-2 (DBCO-vc-seco DUBA) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-2 (DBCO-vc-MMAE)-2 (DBCO-S-DM1) |
Undisclosed |
Undisclosed |
Undisclosed |
||
dCBPR2002-2 (DBCO-vc-seco DUBA)-2 (DBCO-S-DM1) |
Undisclosed |
Undisclosed |
Undisclosed |
IGF-1R
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
uS11661457B2 Ab-E-11 |
US11661457B2+Ab-E-11+payload |
Undisclosed |
Mc-Val-Cit-PABC |
[31] | |
uS11661457B2 Ab-E-12 |
US11661457B2+Ab-E-12+payload |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[31] | |
uS11661457B2 Ab-G-12 |
US11661457B2+Ab-E-12+payload |
Microtubule (MT) |
6-Maleimidocaproic acid |
[31] | |
uS11661457B2 Ab-E-13 |
US11661457B2+Ab-E-13+payload |
Undisclosed |
US11661457B2+Ab-E-13+Linker |
[31] | |
uS11661457B2 Ab-F-13 |
US11661457B2+Ab-F-13+payload |
Undisclosed |
US11661457B2+Ab-F-13+Linker |
[31] | |
uS11661457B2 Ab-G-13 |
US11661457B2+Ab-G-13+payload |
Undisclosed |
6-Maleimidocaproic acid |
[31] | |
uS11661457B2 Ab-E-15 |
US11661457B2+Ab-E-15+payload |
Undisclosed |
Mc-Val-Cit-PABC |
[31] | |
uS11661457B2 Ab-G-15 |
US11661457B2+Ab-G-15+payload |
Undisclosed |
6-Maleimidocaproic acid |
[31] | |
uS11661457B2 Ab-F-61 |
US11661457B2+Ab-F-61+payload |
Undisclosed |
US11661457B2+Ab-F-13+Linker |
[31] | |
uS11661457B2 Ab-F-62 |
US11661457B2+Ab-F-62+payload |
Undisclosed |
US11661457B2+Ab-F-13+Linker |
[31] | |
uS11661457B2 Ab-F-63 |
US11661457B2+Ab-F-63+payload |
Undisclosed |
US11661457B2+Ab-F-13+Linker |
[31] |
IL13Ra2-AB08-v1.0
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
uS11365263B2 ADC#1 |
US11365263B2 ADC#6 payload |
Undisclosed |
US11365263B2 ADC#6 linker |
[32] |
IN202417078684A+Ab1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IN202417078684A+ADC1 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[33] |
IN202417078684A+Ab2
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IN202417078684A+ADC2 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[33] |
IN202417078684A+Ab3
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IN202417078684A+ADC3 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[33] |
IN202417078684A+Ab4
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
IN202417078684A+ADC4 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[33] | |
IN202417078684A+ADC5 |
Mertansine DM4 |
Undisclosed |
SPDB |
[33] | |
IN202417078684A+ADC6 |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[33] | |
IN202417078684A+ADC7 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[33] | |
IN202417078684A+ADC8 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[33] | |
IN202417078684A+ADC9 |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[33] | |
IN202417078684A+ADC10 |
Active metabolite of irinotecan SN38 |
Undisclosed |
Undisclosed |
[33] |
J591
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mC-VC-PAB-MMAE |
Undisclosed |
Undisclosed |
CN116196428A+MC-VC-PAB-MMAE+Linker |
[34] |
KAR
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
KAR-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
KM8047
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
KM8047-SG3249 |
SG3199 |
Undisclosed |
Undisclosed |
[35] |
KS1/4
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
lY203725 |
4-desacetylvinblastine (DAVLB) |
Microtubule (MT) |
A cleavable linker |
||
lY256787 |
4-desacetylvinblastine (DAVLB) |
Microtubule (MT) |
A cleavable linker |
LR004
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
lR004-VC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[36] |
lsotype control mAb3
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2023173132A1 ADC-2 |
P9 |
Undisclosed |
IBAC-suC-PEG4 |
[37] | |
wO2023173132A1 ADC-4 |
P9 |
Undisclosed |
DIBAC-suC-PEG8 |
[37] | |
wO2023173132A1 ADC-6 |
P9 |
Undisclosed |
DIBAC-suC-PEG12 |
[37] | |
wO2023173132A1 ADC-15 |
P9 |
Undisclosed |
Undisclosed |
[37] | |
wO2023173132A1 ADC-29 |
P8 Payload |
Undisclosed |
NH2-PEG8-triazole |
[37] |
M30-H1-L-4P
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
uS12186310B2-1 |
Undisclosed |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[38] | |
uS12186310B2-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-3 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-4 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-5 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-12 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-13 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-14 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-15 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-16 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-17 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-18 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-19 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-20 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-21 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-23 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-24 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-25 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-26 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-27 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-28 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-29 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-30 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-38 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-39 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-40 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-41 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-42 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-43 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-44 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-45 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-46 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-50 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-51 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-52 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-53 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-54 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-55 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] | |
uS12186310B2-56 |
Undisclosed |
Undisclosed |
Undisclosed |
[38] |
mAb-B
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2024140927A1-ADC-B (DAR4) |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[39] |
mAb1DesignA
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mAb1DesignA-SLAE |
SLAuristatin E derivate |
Undisclosed |
DBCO-C4-PEG3-VC-PABC |
[40] | |
mAb1DesignA-LLAE |
LLAuristatin E derivate |
Undisclosed |
DBCO-C6-PEG8-VC-PABC-AE |
[40] |
mAb1DesignB
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mAb1DesignB-SLAE |
SLAuristatin E derivate |
Undisclosed |
DBCO-C4-PEG3-VC-PABC |
[40] | |
mAb1DesignB-LLAE |
LLAuristatin E derivate |
Undisclosed |
DBCO-C6-PEG8-VC-PABC-AE |
[40] |
mAb1DesignC
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mAb1DesignC-SLAE |
SLAuristatin E derivate |
Undisclosed |
DBCO-C4-PEG3-VC-PABC |
[40] | |
mAb1DesignC-LLAE |
LLAuristatin E derivate |
Undisclosed |
DBCO-C6-PEG8-VC-PABC-AE |
[40] |
mAb2DesignA
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mAb2DesignA-SLAE |
SLAuristatin E derivate |
Undisclosed |
DBCO-C4-PEG3-VC-PABC |
[40] | |
mAb2DesignA-LLAE |
LLAuristatin E derivate |
Undisclosed |
DBCO-C6-PEG8-VC-PABC-AE |
[40] |
mAb2DesignB
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mAb2DesignB-SLAE |
SLAuristatin E derivate |
Undisclosed |
DBCO-C4-PEG3-VC-PABC |
[40] | |
mAb2DesignB-LLAE |
LLAuristatin E derivate |
Undisclosed |
DBCO-C6-PEG8-VC-PABC-AE |
[40] |
mAb2DesignC
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
mAb2DesignC-SLAE |
SLAuristatin E derivate |
Undisclosed |
DBCO-C4-PEG3-VC-PABC |
[40] | |
mAb2DesignC-LLAE |
LLAuristatin E derivate |
Undisclosed |
DBCO-C6-PEG8-VC-PABC-AE |
[40] |
Masked chicken-derived anti-IgM (aIgM) antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
algM ADC |
Monomethyl auristatin E |
Undisclosed |
DBCO-PEG4-Val-Cit-PABC |
[41] |
mil40
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
cN112638426B ADC1 |
Tubulin inhibitor B |
Microtubule (MT) |
CN112638426B +ADC1+Linker |
[42] | |
cN112638426B ADC2 |
Tubulin inhibitor B |
Microtubule (MT) |
CN112638426B +ADC2+Linker |
[42] |
mMAB1129
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
control surrogate and mouse SG |
Active metabolite of irinotecan SN38 |
Undisclosed |
CL2A |
[43] |
Mouse IgG2a
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Mouse IgG2a-Val-Cit-Pab-MMAE |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[23] | |
Mouse IgG2a-PEG8-MMAE |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[23] |
mRS7
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
murinized SG |
Active metabolite of irinotecan SN38 |
Undisclosed |
CL2A |
[43] |
Neg-8-8-H16-K222R- hGl
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Neg-8-8-H16-K222R- hGl-LP19 |
Undisclosed |
Undisclosed |
Undisclosed |
[44] |
Neg-8-8-H16-K222R-hG1
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Neg-8-8-H16-K222R- hG1 -LP1 |
Undisclosed |
Undisclosed |
Undisclosed |
[44] |
Neg-8-8-H16-K222R-hGl
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Neg-8-8-H16-K222R- hGl -LP13 |
Undisclosed |
Undisclosed |
Undisclosed |
[44] |
NGS111
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-09 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-17 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
NGS75
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-07 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-15 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-21 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-23 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-25 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
NGS91
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
wO2024131835A1 ADC-08 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] | |
wO2024131835A1 ADC-16 |
Undisclosed |
Undisclosed |
Undisclosed |
[1] |
Nontargeting antibody control 1- 25
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Nontargeting antibody control 1- 25 |
Undisclosed |
Undisclosed |
Undisclosed |
[21] |
Nontargeting antibody control 1- 36
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Nontargeting antibody control 1- 36 |
Undisclosed |
Undisclosed |
Undisclosed |
[21] |
Nontargeting antibody control 1- rifalog
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Nontargeting antibody control 1- rifalog |
Undisclosed |
Undisclosed |
Undisclosed |
[21] |
Nontargeting antibody control 1- rifampicin N
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Nontargeting antibody control 1- rifampicin N |
Undisclosed |
Undisclosed |
Undisclosed |
[21] |
PDL1.24-G1f
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-36 |
AU2020291014A1-Payload-40 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-37 |
AU2020291014A1-Payload-39 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-72 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] |
PDL1.85-G1f
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-48 |
AU2020291014A1-Payload-49 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-49 |
AU2020291014A1-Payload-49 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-73 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-85 |
AU2020291014A1-Payload-69 |
Undisclosed |
Aminobenzazepine-linker Formula II-69 |
[13] | |
AU2020291014A1 IC-88 |
AU2020291014A1-Payload-77 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-89 |
AU2020291014A1-Payload-74 |
Undisclosed |
Undisclosed |
[13] |
PR300159
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
pR300159-B81 |
NZ818359A+PR300159-B81+payload |
Undisclosed |
NZ818359A+PR300159-B81+Linker |
[45] | |
pR300159-B71 |
NZ818359A+PR300159-B81+payload |
Undisclosed |
NZ818359A+PR300159-B71+Linker |
[45] |
PR300159-8
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
pR300159-8-B81 |
NZ818359A+PR300159-B81+payload |
Undisclosed |
NZ818359A+PR300159-B81+Linker |
[45] |
PR300186
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
pR300186-B81 |
NZ818359A+PR300159-B81+payload |
Undisclosed |
NZ818359A+PR300159-B81+Linker |
[45] | |
pR300186-B71 |
NZ818359A+PR300159-B81+payload |
Undisclosed |
NZ818359A+PR300159-B71+Linker |
[45] |
PR300186-10
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
pR300186-10-B81 |
NZ818359A+PR300159-B81+payload |
Undisclosed |
NZ818359A+PR300159-B81+Linker |
[45] |
Protease-activated chicken-derived anti-IgM (aIgM) antibody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Masked Protease-activated CH2-aIgM ADC |
Monomethyl auristatin E |
Undisclosed |
DBCO-PEG4-Val-Cit-PABC |
[41] |
Rab64
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
surrogate SG |
Active metabolite of irinotecan SN38 |
Undisclosed |
CL2A |
[43] |
Rabbit derived VL single-domain Anti-ody
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
VL-DAB31-SN38 |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
Mal-Cyc-PEG3-DAB |
[46] | |
ROS-responsive SN38 ADC |
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
Mal-Cyc-PEG3-DAB |
[46] |
rat IgG2b
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-47 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] |
RKAA
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
RKAA-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
RKAAR
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
RKAAR-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] | |
RKAAR-PABC-Exa |
Exatecan |
Undisclosed |
Mc-Val-Cit-PABC |
[10] | |
RKAAR-EDA-CS |
cortisol |
Undisclosed |
Undisclosed |
[10] |
ROSPATAMAB
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
iGAC-92 |
IG-L-18 Payload |
Undisclosed |
IG-L-25 linker |
[47] |
RRK
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
RRK-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] | |
RRK-PABC-Exa |
Exatecan |
Undisclosed |
Mc-Val-Cit-PABC |
[10] |
RRKAY
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
RRKAY-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[10] |
S-49-8
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN119019562A ADC1 S-49-8 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] | |
CN119019562A ADC2 S-49-8 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] | |
CN119019562A ADC3 S-49-8 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] | |
CN119019562A ADC4 S-49-8 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] |
S-60-6
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CN119019562A ADC1 S-60-6 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] | |
CN119019562A ADC2 S-60-6 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] | |
CN119019562A ADC3 S-60-6 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] | |
CN119019562A ADC4 S-60-6 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[48] |
S423
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
KR1020250011922A ADC-S423 |
Undisclosed |
Undisclosed |
Undisclosed |
[49] |
S426
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
KR1020250011922A ADC-S426 |
Undisclosed |
Undisclosed |
Undisclosed |
[49] |
TPP-5657
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
WO2024105206A1 16i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 17i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 18i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 19i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 20i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 21i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 22i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 23i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 24i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 25i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 26i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 27i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 28i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 33i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 35i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 41i-5657 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 16i-5657 2 |
Mdo-cpt |
DNA topoisomerase I (TOP1) |
16i-5657 Linker |
[50] | |
WO2024105206A1 17i-5657 2 |
41i-5657 Payload |
Undisclosed |
17i-5657 Linker |
[50] | |
WO2024105206A1 18i-5657 2 |
41i-5657 Payload |
Undisclosed |
18i-5657 Linker |
[50] | |
WO2024105206A1 19i-5657 2 |
Mdo-cpt |
DNA topoisomerase I (TOP1) |
6i-5657 Linker |
[50] | |
WO2024105206A1 20i-5657 2 |
41i-5657 Payload |
Undisclosed |
17i-5657 Linker |
[50] | |
WO2024105206A1 21i-5657 2 |
41i-5657 Payload |
Undisclosed |
21i-5657 Linker |
[50] | |
WO2024105206A1 22i-5657 2 |
22i-5657 Payload |
Undisclosed |
22i-5657 Linker |
[50] | |
WO2024105206A1 23i-5657 2 |
Mdo-cpt |
DNA topoisomerase I (TOP1) |
23i-5657 Linker |
[50] | |
WO2024105206A1 24i-5657 2 |
41i-5657 Payload |
Undisclosed |
24i-5657 Linker |
[50] | |
WO2024105206A1 25i-5657 2 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 26i-5657 2 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
WO2024105206A1 27i-5657 2 |
Mdo-cpt |
DNA topoisomerase I (TOP1) |
22i-5657 Linker |
[50] | |
WO2024105206A1 28i-5657 2 |
Mdo-cpt |
DNA topoisomerase I (TOP1) |
6i-5657 Linker |
[50] | |
WO2024105206A1 33i-5657 2 |
Monomethyl auristatin E |
Microtubule (MT) |
22i-5657 Linker |
[50] | |
WO2024105206A1 35i-5657 2 |
41i-5657 Payload |
Undisclosed |
22i-5657 Linker |
[50] | |
WO2024105206A1 41i-5657 2 |
41i-5657 Payload |
Undisclosed |
41i-5657 Linker |
[50] | |
wO2024105206A1 1i-5657 |
CHH0170, 1i-5657, Payload |
Undisclosed |
32p-Avelu Linker |
[50] | |
wO2024105206A1 2i-5657 |
Camptothecin |
Undisclosed |
2i-5657 Linker |
[50] | |
wO2024105206A1 3i-5657 |
Ac-Exatecan |
DNA topoisomerase I (TOP1) |
32p-Avelu Linker |
[50] | |
wO2024105206A1 4i-5657 |
CHH0177, 4i-5657, Payload |
Undisclosed |
CHH0177, 4i-5657, Linker |
[50] | |
wO2024105206A1 5i-5657 |
CHH0177, 4i-5657, Payload |
Undisclosed |
3i-5657 Linker |
[50] | |
wO2024105206A1 6i-5657 |
6i-5657 Payload |
DNA topoisomerase I (TOP1) |
3i-5657 Linker |
[50] | |
wO2024105206A1 7i-5657 |
CHH0183, 7i-5657, Payload |
Undisclosed |
Undisclosed |
[50] | |
wO2024105206A1 8i-5657 |
Mdo-cpt |
DNA topoisomerase I (TOP1) |
Undisclosed |
[50] | |
wO2024105206A1 9i-5657 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
wO2024105206A1 10i-5657 |
Ac-Exatecan |
DNA topoisomerase I (TOP1) |
CHH0187, 10i-5657, Linker |
[50] | |
wO2024105206A1 11i-5657 |
Undisclosed |
Undisclosed |
Undisclosed |
[50] | |
wO2024105206A1 12i-5657 |
CHH0189, 12i-5657, Payload |
Undisclosed |
CHH0189, 12i-5657, Linker |
[50] | |
wO2024105206A1 13i-5657 |
CHH0191, 13i-5657, Payload |
Undisclosed |
CHH0191, 13i-5657, Linker |
[50] | |
wO2024105206A1 14i-5657 |
CHH0192, 14i-5657, Payload 1; CHH0192, 14i-5657, Payload 2 |
Undisclosed |
CHH0192, 14i-5657, Linker1; CHH0192, 14i-5657, Linker2 |
[50] | |
wO2024105206A1 15i-5657 |
CHH0193, 15i-5657, Payload 1; CHH0193, 15i-5657, Payload 2 |
Undisclosed |
Undisclosed |
[50] |
Tras-Glf-N297A
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
AU2020291014A1 IC-58 |
AU2020291014A1-Payload-35 |
Undisclosed |
Undisclosed |
[13] | |
AU2020291014A1 IC-64 |
AU2020291014A1-Payload-69 |
Undisclosed |
Aminobenzazepine-linker Formula II-69 |
[13] |
Tz
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
Tz-IR700 |
IRDye 700DX |
Undisclosed |
NHS ester linker |
[51] |
YTH24.5
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
YTH24.5-SG3249 |
Undisclosed |
Undisclosed |
Undisclosed |
[52] | |
YTH24.5-SG3376 |
Undisclosed |
Undisclosed |
Undisclosed |
[52] |
undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
dS3610 |
Undisclosed |
Stimulator of interferon genes protein (STING1) |
Undisclosed |
||
DB-1202 |
Undisclosed |
Undisclosed |
Undisclosed |
||
PHN-010 |
TOP1 inhibitor |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
||
SC-007 |
PBD dimer |
Human deoxyribonucleic acid (hDNA) |
Undisclosed |
||
SC-005 |
PBD dimer |
Human deoxyribonucleic acid (hDNA) |
Undisclosed |
[53] | |
IgG2-ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[272] | |
Anti-0079b_AsnAsnPABC_MMAE |
Monomethyl auristatin E |
Undisclosed |
AsnAsnPABC |
[273] | |
FG-ADC (DAR 4) |
Mertansine DM1 |
Undisclosed |
MA-FG-P12 |
[274] | |
FG-ADC (DAR 8) |
Mertansine DM1 |
Undisclosed |
MA-FG-P12 |
[274] | |
VAG-ADC (DAR 4) |
Mertansine DM1 |
Undisclosed |
MA-VAG-P12 |
[274] | |
VAG-ADC (DAR 8) |
Mertansine DM1 |
Undisclosed |
MA-VAG-P12 |
[274] | |
Control to 8D302-MMAE |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[275] | |
Control to 8D302-DXd |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[275] | |
Isotype-SG3249 |
SG3199 |
Undisclosed |
Undisclosed |
[52] | |
Isotype-SG3376 |
SG3199 |
Undisclosed |
Undisclosed |
[52] | |
IgG-MMAE 8 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[276] | |
Control-MMAE-DAR3 |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[27] | |
Control-DXd-DAR8 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[27] | |
39298786 ADC2 (DAR8) |
AZ14170132 |
Undisclosed |
Val-Ala-PEG8 |
[277] | |
39298786 ADC2 (DAR4) |
AZ14170132 |
Undisclosed |
Val-Ala-PEG8 |
[277] | |
38770747 ADC 1 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 2 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 3 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 4 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 5 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 6 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 7 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 8 (DAR 2) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 1 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 2 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 3 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 4 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 5 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 6 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 7 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
38770747 ADC 8 (DAR 4) |
Undisclosed |
Undisclosed |
Undisclosed |
[278] | |
IgG-vedotin |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[279] | |
40300109 ADC 2 |
NLRP3 Agonist 2 |
Undisclosed |
Undisclosed |
[280] | |
40300109 ADC 4 |
NLRP3 Agonist 4 |
Undisclosed |
Mc-Val-Cit-PABC |
[280] | |
40300109 ADC 5 |
NLRP3 Agonist 3 |
Undisclosed |
Undisclosed |
[280] | |
40300109 ADC 6 |
NLRP3 Agonist 3 |
Undisclosed |
Undisclosed |
[280] | |
40300109 ADC 7 |
NLRP3 Agonist 3 |
Undisclosed |
Undisclosed |
[280] | |
40300109 ADC 8 |
NLRP3 Agonist 3 |
Undisclosed |
Undisclosed |
[280] | |
IgG-NPLG-SN38 |
Active metabolite of irinotecan SN38 |
Undisclosed |
NPLG |
[281] | |
38679234 ADC1-FL |
Fluorescein |
Undisclosed |
Undisclosed |
[282] | |
38679234 ADC1-FY |
Eosin Y |
Undisclosed |
Undisclosed |
[282] | |
38679234 ADC1-MMAE |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[282] | |
38679234 ADC1-DM1 |
Mertansine DM1 |
Undisclosed |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[282] | |
38679234 ADC2 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[282] | |
39424599 ADC-10B |
Undisclosed |
Undisclosed |
Electron-deficient sulfonamide-based cleavable linker 10 |
[283] | |
39424599 ADC-S32B |
Undisclosed |
Undisclosed |
Electron-deficient Disulfide-based cleavable linker 32 |
[283] | |
39424599 ADC-S35B |
Undisclosed |
Undisclosed |
S35 linker |
[283] | |
39948340 ADC 3 (nobinding) |
TLR7 payload 1 |
Undisclosed |
39948340 Linker |
[284] | |
Isotype-MMAE (gylcan conjugation) |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[23] | |
Isotype-MMAE (Lysine conjugation) |
Monomethyl auristatin E |
Undisclosed |
Undisclosed |
[23] | |
Control-STINGa |
STINGa |
Undisclosed |
Undisclosed |
[285] | |
hIgGFc-DM1 (38127423) |
Mertansine DM1 |
Undisclosed |
Undisclosed |
[286] | |
ASAK-22 |
KRM-1657 |
Undisclosed |
Mc-Val-Ala-PABC |
[287] | |
ASAC-01 |
KRM-1657 |
Undisclosed |
Undisclosed |
[287] | |
ASAC-02 |
KRM-1657 |
Undisclosed |
M6 Linker |
[287] | |
37788373 ADC24 |
(R)-Budesonide |
Undisclosed |
MP-Ala-Ala-RG-9 |
[288] | |
hIgG-MMAE |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[289] | |
mAb-ZnPcGal4 conjugate |
ZnPcGal4 |
Undisclosed |
Undisclosed |
[290] | |
38389885 ADC 21 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 22 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 23 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 24 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 25 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 26 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 27 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 28 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 29 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 30 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 31 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 32 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 33 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 34 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 35 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 36 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 37 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 38 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 39 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
38389885 ADC 40 |
GRM payload (38389885) |
Undisclosed |
DL1 linker |
[291] | |
Thio-1b |
Undisclosed |
Undisclosed |
Undisclosed |
[292] | |
Thio-2b |
Undisclosed |
Undisclosed |
Undisclosed |
[292] | |
IgG IB-Y |
IB-Y |
Undisclosed |
Undisclosed |
[293] | |
hIgGFc-DM1 (36909522) |
Mertansine DM1 |
Undisclosed |
Undisclosed |
[294] | |
scFv-PEG4-DM1 |
Mertansine DM1 |
Undisclosed |
Undisclosed |
[295] | |
scFv-PEG4-DM4 |
Mertansine DM4 |
Undisclosed |
Undisclosed |
[295] | |
TDC MMAE |
Monomethyl auristatin E |
Undisclosed |
Mc-Val-Cit-PABC |
[296] | |
ProPBD-ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[297] | |
ADCT-241 |
PL2202 |
Undisclosed |
Undisclosed |
[298] | |
Topo1i/PARPi dual-payload ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[299] | |
PA289 ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[300] | |
ThiOBI ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[301] | |
AMB304 |
Undisclosed |
Undisclosed |
Undisclosed |
[302] | |
CAB-ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[303] | |
DKIF976 DAC |
dKIF976 |
Undisclosed |
Undisclosed |
[304] | |
Control-AL1- LP1 |
US12209180B2 P3 |
Undisclosed |
Anti-Her2-AL1- LP1 LINKER |
[305] | |
Control-AL1- LP2 |
US12209180B2 P3 |
Undisclosed |
Anti-Her2-AL1- LP2 LINKER |
[305] | |
Control-AL1- LP20 |
US12209180B2 P3 |
Undisclosed |
Anti-Her2-AL1- LP20 LINKER |
[305] | |
Control-AL1- LP22 |
US12209180B2 P3 |
Undisclosed |
Anti-Her2-AL1- LP22 linker |
[305] | |
Control-AL1- LP23 |
Undisclosed |
Undisclosed |
Anti-Her2-AL1- LP23 linker |
[305] | |
Control-AL1- LP24 |
Undisclosed |
Undisclosed |
Anti-Her2-AL1- LP24 linker |
[305] | |
Control-ALl-LP1 |
US12209180B2 P3 |
Undisclosed |
Anti-Her2-AL1- LP1 LINKER |
[305] | |
Control-AL1- LP35 |
Undisclosed |
Undisclosed |
Anti-Her2-AL1- LP35 LINKER linker |
[305] | |
Control-AL1- LP32 |
Undisclosed |
Undisclosed |
Anti-Her2-AL1- LP32 linker |
[305] | |
Control-AL1- LP39 |
Undisclosed |
Undisclosed |
Undisclosed |
[305] | |
Control-AL1- LP38 |
Undisclosed |
Undisclosed |
Anti-Her2-AL1- LP38 linker |
[305] | |
WO2024043319A1 72-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 72-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 73 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 74 |
WO2024043319A1 74 payload |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 75-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 75-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 75-3 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 76 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 77 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
WO2024043319A1 87 |
Undisclosed |
Undisclosed |
Undisclosed |
[306] | |
deJ591-A |
Undisclosed |
Undisclosed |
Undisclosed |
[307] | |
deJ591-E |
Undisclosed |
Undisclosed |
Undisclosed |
[307] | |
deJ591-D |
Undisclosed |
Undisclosed |
Undisclosed |
[307] | |
BI2-A |
Undisclosed |
Undisclosed |
Undisclosed |
[307] | |
BI2-E |
Undisclosed |
Undisclosed |
Undisclosed |
[307] | |
BI2-D |
Undisclosed |
Undisclosed |
Undisclosed |
[307] | |
CN108883196A 5F9-CDA-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[308] | |
CN108883196A 5F9-CDA-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[308] | |
CN108883196A 5F9-CDA-3 |
Undisclosed |
Undisclosed |
Undisclosed |
[308] | |
hLL2-IgG1-Tap-18Hr1 |
Undisclosed |
Undisclosed |
Undisclosed |
[309] | |
hLL2-IgG1-Tap-18Hr2 |
Undisclosed |
Undisclosed |
Undisclosed |
[309] | |
CN107614020A 1MB-101 |
Undisclosed |
Undisclosed |
Undisclosed |
[310] | |
CN107614020A 1MB-102 |
Undisclosed |
Undisclosed |
Undisclosed |
[310] | |
CN107614020A 1MB-991 |
Undisclosed |
Undisclosed |
Undisclosed |
[310] | |
CN107614020A 1MB-992 |
Undisclosed |
Undisclosed |
Undisclosed |
[310] | |
CN107635405A CN107635405A 19 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 20 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 21 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 22 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 23 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 24 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 25 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 26 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 27 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 28 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 29 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 30 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 31 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 32 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 33 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 34 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
CN107635405A CN107635405A 35 |
Undisclosed |
Undisclosed |
Undisclosed |
[311] | |
US20200023071A1 Example 2 |
US20200023071A1 Example 2 payload |
Undisclosed |
Undisclosed |
[312] | |
US20200023071A1 Example 3 |
Undisclosed |
Undisclosed |
Undisclosed |
[312] | |
anti-PanP-DM1 |
Undisclosed |
Undisclosed |
Undisclosed |
[313] | |
BCN-B12 B12-v1a-145 |
Undisclosed |
Undisclosed |
linker145 |
[314] | |
WO2019126691A1 Conjugate No.138 |
Conjugate No.138 Payload |
Undisclosed |
Conjugate No.138 Linker |
[315] | |
WO2019126691A1 Conjugate No.139 |
undisclosed |
Undisclosed |
Conjugate No.138 Linker |
[315] | |
WO2019126691A1 Conjugate No.140 |
Conjugate No.140 Payload |
Undisclosed |
Conjugate No.138 Linker |
[315] | |
WO2019126691A1 Conjugate No.141 |
Conjugate No.141 Payload |
Undisclosed |
Conjugate No.138 Linker |
[315] | |
WO2019126691A1 Conjugate No.142 |
Conjugate No.136 Payload |
Undisclosed |
Conjugate No.57 Linker |
[315] | |
WO2019126691A1 Conjugate No.143 |
Conjugate No.136 Payload |
Undisclosed |
Conjugate No.71 Linker |
[315] | |
WO2019126691A1 Conjugate No.144 |
Conjugate No.136 Payload |
Undisclosed |
Conjugate No.67 Linker |
[315] | |
WO2019126691A1 Conjugate No.145 |
Conjugate No.136 Payload |
Undisclosed |
Conjugate No.73 Linker |
[315] | |
WO2019126691A1 Conjugate No.146 |
Conjugate No.136 Payload |
Undisclosed |
DL18 linker |
[315] | |
WO2019126691A1 Conjugate No.147 |
Conjugate No.94 Payload |
Undisclosed |
Conjugate No.147 Linker |
[315] | |
WO2019126691A1 Conjugate No.148 |
Conjugate No.148 Payload |
Undisclosed |
Conjugate No.147 Linker |
[315] | |
WO2019126691A1 Conjugate No.149 |
Conjugate No.94 Payload |
Undisclosed |
Conjugate No.147 Linker |
[315] | |
WO2019126691A1 Conjugate No.150 |
Conjugate No.112 Payload |
Undisclosed |
Conjugate No.112 Linker |
[315] | |
WO2019126691A1 Conjugate No.151 |
Conjugate No.112 Payload |
Undisclosed |
Conjugate No.151 Linker |
[315] | |
WO2019126691A1 Conjugate No.152 |
Conjugate No.94 Payload |
Undisclosed |
Conjugate No.152 Linker |
[315] | |
WO2019126691A1 Conjugate No.153 |
Conjugate No.94 Payload |
Undisclosed |
Conjugate No.119 Linker |
[315] | |
WO2019126691A1 Conjugate No.154 |
Conjugate No.137 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.155 |
Conjugate No.155 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.156 |
Conjugate No.156 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.157 |
Conjugate No.157 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.158 |
Conjugate No.158 Payload |
Undisclosed |
Conjugate No.94 Linker |
[315] | |
WO2019126691A1 Conjugate No.159 |
Conjugate No.159 Payload |
Undisclosed |
Conjugate No.94 Linker |
[315] | |
WO2019126691A1 Conjugate No.160 |
Conjugate No.160 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.161 |
Conjugate No.161 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.162 |
Conjugate No.162 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.163 |
Conjugate No.163 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.164 |
Conjugate No.164 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.165 |
Conjugate No.165 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.166 |
Conjugate No.166 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.167 |
Conjugate No.167 Payload |
Undisclosed |
Conjugate No.167 Linker |
[315] | |
WO2019126691A1 Conjugate No.168 |
Conjugate No.168 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.169 |
Conjugate No.169 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.170 |
Conjugate No.170 Payload |
Undisclosed |
Conjugate No.167 Linker |
[315] | |
WO2019126691A1 Conjugate No.171 |
Conjugate No.171 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.172 |
Conjugate No.172 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.173 |
Conjugate No.173 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.174 |
Conjugate No.174 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.175 |
Conjugate No.175 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.176 |
Conjugate No.176 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2019126691A1 Conjugate No.177 |
Conjugate No.177 Payload |
Undisclosed |
Conjugate No.105 Linker |
[315] | |
WO2024138000A1 FelD1 Ab |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (AL11a)4 |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (AL2a)4 |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (AL3a)4 |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (AL7)4 |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (BL1)3.9 |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (BL3b)3.8 |
Undisclosed |
Undisclosed |
Undisclosed |
[316] | |
FelD1- (AL7-LP1)3.9 |
aHer2- (AL6-LP1)<sub>3.6</sub> Payload |
Undisclosed |
aHer2- (AL7-LP1)<sub>3.7</sub> Linker |
[316] | |
FelD1- (AL7-LP13)7.3 |
aHer2- (AL6-LP1)<sub>3.6</sub> Payload |
Undisclosed |
aHer2- (AL7-LP13)<sub>7.3</sub> Linker |
[316] | |
FelD1- (AL7-LP2)3.80 |
aHer2- (AL7-LP2)<sub>3.83</sub> Payload |
Undisclosed |
aHer2- (AL7-LP2)<sub>3.83</sub> Linker |
[316] | |
FelD1- (AL7-LP3)3.82 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
aHer2- (AL7-LP2)<sub>3.83</sub> Linker |
[316] | |
FelD1- (AL7-LP4)3.82 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
aHer2- (AL7-LP2)<sub>3.83</sub> Linker |
[316] | |
FelD1- (AL7-LP5)3.69 |
aHer2- (AL7-LP5)<sub>3.80</sub> Payload |
Undisclosed |
aHer2- (AL7-LP5)<sub>3.80</sub> Linker |
[316] | |
FelD1- (AL7-LP7)3.68 |
aHer2- (AL7-LP7)<sub>3.70</sub> Payload |
Undisclosed |
aHer2- (AL7-LP2)<sub>3.83</sub> Linker |
[316] | |
FelD1- (AL7-LP9)3.89 |
undisclosed |
Undisclosed |
aHer2- (AL7-LP2)<sub>3.83</sub> Linker |
[316] | |
FelD1- (AL7-LP12)3.83 |
aHer2- (AL7-LP12)<sub>3.82</sub> Payload |
Undisclosed |
aHer2- (AL7-LP12)<sub>3.82</sub> Linker |
[316] | |
FelD1- (AL4c-LP1B)3.45 |
aHer2- (AL4c-LP1B)<sub>3.49</sub> Payload |
Undisclosed |
aHer2- (AL4c-LP1B)<sub>3.49</sub> Linker |
[316] | |
FelD1- (AL11a-LP1)4 |
aHer2- (AL6-LP1)<sub>3.6</sub> Payload |
Undisclosed |
aHer2- (AL7-LP2)<sub>3.83</sub> Linker |
[316] | |
FelD1- (AL11a-LP13)7.3 |
aHer2- (AL6-LP1)<sub>3.6</sub> Payload |
Undisclosed |
aHer2- (AL11a-LP13)<sub>7.8</sub> Linker |
[316] | |
FelD1- (AL11a-LP15)7.0 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
aHer2- (AL11a-LP15)<sub>7.6</sub> Linker |
[316] | |
FelD1- (BL1-LP1)7.6 |
aHer2- (AL6-LP1)<sub>3.6</sub> Payload |
Undisclosed |
aHer2- (BL1-LP1)<sub>7.7</sub> Linker |
[316] | |
FelD1- (BL1-LP13)15.00 |
aHer2- (AL6-LP1)<sub>3.6</sub> Payload |
Undisclosed |
aHer2- (BL1-LP13)<sub>14.88</sub> Linker |
[316] | |
FelD1- (BL3b-LP1)7.1 |
aHer2- (AL4c-LP1B)<sub>3.49</sub> Payload |
Undisclosed |
aHer2- (BL3b-LP1)<sub>7.5</sub> Linker |
[316] | |
FelD1 1- (Mc-GGFG-DXD)7.5 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[316] | |
FelD1 2- (Mc-GGFG-DXD)7.5 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[316] | |
FelD1 3- (Mc-GGFG-DXD)7.5 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[316] | |
FelD1 1- (Mc-GGFG-DXD)7.0 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[316] | |
FelD1 2- (Mc-GGFG-DXD)7.0 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[316] | |
FelD1 3- (Mc-GGFG-DXD)7.0 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[316] | |
US20230022596A1 B-1 |
B-1 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-2 |
B-2 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-3 |
B-3 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-4 |
B-4 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-5 |
B-5 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-6 |
B-6 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-7 |
B-7 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-8 |
B-8 Payload |
Undisclosed |
B-1 Linker |
[317] | |
US20230022596A1 B-9 |
B-1 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-10 |
B-2 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-11 |
B-3 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-12 |
B-4 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-13 |
B-5 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-14 |
B-6 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-15 |
B-7 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-16 |
B-8 Payload |
Undisclosed |
B-9 Linker |
[317] | |
US20230022596A1 B-17 |
B-1 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-18 |
B-2 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-19 |
B-3 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-20 |
B-4 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-21 |
B-5 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-22 |
B-6 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-23 |
B-7 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-24 |
B-8 Payload |
Undisclosed |
B-17 Linker |
[317] | |
US20230022596A1 B-25 |
B-1 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-26 |
B-2 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-27 |
B-3 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-28 |
B-4 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-29 |
B-5 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-30 |
B-6 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-31 |
B-7 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-32 |
B-7 Payload |
Undisclosed |
B-25 Linker |
[317] | |
US20230022596A1 B-33 |
B-1 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-34 |
B-2 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-35 |
B-3 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-36 |
B-4 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-37 |
B-5 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-38 |
B-6 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-39 |
B-7 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-40 |
B-8 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-41 |
B-1 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-42 |
B-2 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-43 |
B-3 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-44 |
B-4 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-45 |
B-5 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-46 |
B-6 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-47 |
B-7 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-48 |
B-8 Payload |
Undisclosed |
B-33 Linker |
[317] | |
US20230022596A1 B-49 |
B-1 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-50 |
B-2 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-51 |
B-3 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-52 |
B-4 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-53 |
B-5 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-54 |
B-6 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-55 |
B-7 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-56 |
B-8 Payload |
Undisclosed |
B-49 Linker |
[317] | |
US20230022596A1 B-57 |
B-1 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-58 |
B-2 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-59 |
B-3 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-60 |
B-4 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-61 |
B-5 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-62 |
B-6 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-63 |
B-7 Payload |
Undisclosed |
B-57 Linker |
[317] | |
US20230022596A1 B-64 |
B-8 Payload |
Undisclosed |
B-57 Linker |
[317] | |
T-1-AB |
T-1-AB Payload |
Undisclosed |
T-1-AB Linker |
[318] | |
T-3-AB 0.5 |
T-3-AB Payload |
Undisclosed |
T-3-AB Linker |
[318] | |
T-4-AB 0.42 |
T-4-AB Payload |
Undisclosed |
T-4-AB Linker |
[318] | |
AU2023281032A1 ADC-1 |
Monomethyl auristatin E |
Microtubule (MT) |
AU2023281032A1 ADC-1 linker |
[319] | |
IgG-P1-L12-P4 |
P4 payload |
Undisclosed |
L12 linker |
[320] | |
mT-GGFG- Compound 104 |
TW202426058A+MT-GGFG-Compound 104+payload |
Undisclosed |
Undisclosed |
[323] | |
mT-GGFG- Compound 108 |
TW202426058A+MT-GGFG-Compound 108+payload |
Undisclosed |
Undisclosed |
[323] | |
mT-GGFG- Compound 127 |
TW202426058A+MT-GGFG-Compound 127+payload |
Undisclosed |
Undisclosed |
[323] | |
mT-GGFG-AM-Compound136 |
TW202426058A+MT-AM-GGFG-Compound 136+payload |
Undisclosed |
TW202426058A+MT-AM-GGFG-Compound 136+Linker |
[323] | |
mT-GGFG-AM-Compound139 |
TW202426058A+MT-AM-GGFG-Compound 136+payload |
Undisclosed |
TW202426058A+MT-AM-GGFG-Compound 139+Linker |
[323] | |
mT-GGFG-AM-Compound129 |
TW202426058A+MT-AM-GGFG-Compound 129+payload |
Undisclosed |
CN115160403A+B17+Linker |
[323] | |
mT-GGFG-AM-Compound113 |
TW202426058A+MT-AM-GGFG-Compound 113+payload |
Undisclosed |
Undisclosed |
[323] | |
mT-GGFG-AM-Compound141 |
TW202426058A+MT-AM-GGFG-Compound 141+payload |
Undisclosed |
Undisclosed |
[323] | |
mC-GGFG-AM-Compound141 |
TW202426058A+MC-GGFG-AM-Compound141+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[323] | |
mT-GGFG-AM-Compound117 |
TW202426058A+MC-GGFG-AM-Compound117+payload |
Undisclosed |
TW202426058A+MT-GGFG-AM-Compound117+Linker |
[323] | |
mT-GGFG-AM-Compound118 |
TW202426058A+MT-GGFG-AM-Compound118+payload |
Undisclosed |
TW202426058A+MT-GGFG-AM-Compound118+Linker |
[323] | |
mC-GGFG-AM-Compound139 |
TW202426058A+MC-GGFG-AM-Compound139+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[323] | |
mT-GGFG-Compound140 |
10NH2-11F-Camptothecin |
DNA topoisomerase I (TOP1) |
CN115160403A+B17+Linker |
[323] | |
mT-GGFG-Compound141 |
FD5 |
DNA topoisomerase I (TOP1) |
CN115160403A+B17+Linker |
[323] | |
mT-GGFG-Compound145 |
FD5 |
DNA topoisomerase I (TOP1) |
CN115160403A+B17+Linker |
[323] | |
mT-GGFG-Compound148 |
FD7 |
DNA topoisomerase I (TOP1) |
CN115160403A+B17+Linker |
[323] | |
mC-GGFG-Compound140 |
TW202426058A+MC-GGFG-Compound140+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[323] | |
mT-GGFG-Compound142 |
TW202426058A+MT-GGFG-Compound142+payload |
Undisclosed |
CN115160403A+B17+Linker |
[323] | |
mC-GGFG-Compound141 |
TW202426058A+MC-GGFG-Compound141+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[323] | |
wO2024133815A1 Structure (4) |
WO2024133815A1+structure (4)+payload |
Undisclosed |
WO2024133815A1+structure (4)+Linker |
[324] | |
cN118878620A ADC Drug linker 1 |
CN118878620A+Drug linker 1+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 2 |
CN118878620A+Drug linker 2+payload |
Undisclosed |
CN118878620A+Drug linker 2+Linker |
[325] | |
cN118878620A ADC Drug linker 3 |
CN118878620A+Drug linker 3+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 4 |
CN118878620A+Drug linker 4+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 5 |
CN118878620A+Drug linker 5+payload |
Undisclosed |
CN118878620A+Drug linker 5+Linker |
[325] | |
cN118878620A ADC Drug linker 6 |
CN118878620A+Drug linker 5+payload |
Undisclosed |
CN118878620A+Drug linker 6+Linker |
[325] | |
cN118878620A ADC Drug linker 7 |
CN118878620A+Drug linker 7+payload |
Undisclosed |
CN118878620A+Drug linker 7+Linker |
[325] | |
cN118878620A ADC Drug linker 8 |
CN118878620A+Drug linker 8+payload |
Undisclosed |
CN118878620A+Drug linker 8+Linker |
[325] | |
cN118878620A ADC Drug linker 9 |
CN118878620A+Drug linker 9+payload |
Undisclosed |
CN118878620A+Drug linker 7+Linker |
[325] | |
cN118878620A ADC Drug linker 10 |
CN118878620A+Drug linker 9+payload |
Undisclosed |
CN118878620A+Drug linker 10+Linker |
[325] | |
cN118878620A ADC Drug linker 11 |
CN118878620A+Drug linker 9+payload |
Undisclosed |
CN118878620A+Drug linker 11+Linker |
[325] | |
cN118878620A ADC Drug linker 12 |
CN118878620A+Drug linker 9+payload |
Undisclosed |
CN118878620A+Drug linker 12+Linker |
[325] | |
cN118878620A ADC Drug linker 13 |
CN118878620A+Drug linker 9+payload |
Undisclosed |
CN118878620A+Drug linker 11+Linker |
[325] | |
cN118878620A ADC Drug linker 14 |
CN118878620A+Drug linker 14+payload |
Undisclosed |
CN118878620A+Drug linker 14+Linker |
[325] | |
cN118878620A ADC Drug linker 16 |
CN118878620A+Drug linker 16+payload |
Undisclosed |
Undisclosed |
[325] | |
cN118878620A ADC Drug linker 15 |
CN118878620A+Drug linker 14+payload |
Undisclosed |
CN118878620A+Drug linker 11+Linker |
[325] | |
cN118878620A ADC Drug linker 17 |
CN118878620A+Drug linker 17+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 18 |
CN118878620A+Drug linker 18+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 19 |
CN118878620A+Drug linker 19+payload |
Undisclosed |
CN118878620A+Drug linker 19+Linker |
[325] | |
cN118878620A ADC Drug linker 20 |
CN118878620A+Drug linker 20+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 21 |
CN118878620A+Drug linker 21+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 22 |
CN118878620A+Drug linker 22+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 23 |
CN118878620A+Drug linker 23+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[325] | |
cN118878620A ADC Drug linker 24 |
CN118878620A+Drug linker 24+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 25 |
CN118878620A+Drug linker 25+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
cN118878620A ADC Drug linker 26 |
CN118878620A+Drug linker 26+payload |
Undisclosed |
CN118878620A+Drug linker 1+Linker |
[325] | |
wO2022197877A1 compound 4 |
WO2022197877A1+compound 4+payload |
Undisclosed |
WO2022197877A1+compound 4+Linker |
[327] | |
wO2022197877A1 compound 5 |
WO2022197877A1+compound 5+payload |
Undisclosed |
WO2022197877A1+compound 4+Linker |
[327] | |
wO2022197877A1 compound 6 |
WO2022197877A1+compound 6+payload |
Undisclosed |
WO2022197877A1+compound 6+Linker |
[327] | |
wO2022197877A1 compound 7 |
WO2022197877A1+compound 7+payload |
Undisclosed |
WO2022197877A1+compound 6+Linker |
[327] | |
synthesis Example 2 |
WO2022197877A1+Synthesis Example 2+payload |
Undisclosed |
Mc-Val-Cit-PABC |
[327] | |
wO2022197877A1 compound 3 |
WO2022197877A1+compound 3+payload |
Undisclosed |
Mc-Val-Cit-PABC |
[327] | |
wO2022197877A1 compound 10 |
WO2022197877A1+compound 10+payload |
Undisclosed |
WO2022197877A1+compound 10+Linker |
[327] | |
wO2022197877A1 compound 8 |
WO2022197877A1+compound 8+payload |
Undisclosed |
WO2022197877A1+compound 10+Linker |
[327] | |
wO2022197877A1 compound 9 |
WO2022197877A1+compound 9+payload |
Undisclosed |
WO2022197877A1+compound 10+Linker |
[327] | |
cN119072334A Formula 6 |
CN119072334A+Formula 6+payload |
Undisclosed |
Undisclosed |
[328] | |
cN119072334A Formula 7 |
CN119072334A+Formula 7+payload |
Undisclosed |
CN119072334A+Formula 7+Linker |
[328] | |
cN119072334A Formula 8 |
Topo1 inhibitor H |
DNA topoisomerase I (TOP1) |
CN119072334A+Formula 8+Linker |
[328] | |
mC-VaI-Cit-PAB-MMAE |
Undisclosed |
Undisclosed |
CN119072334A+MC-VaI-Cit-PAB-MMAE+Linker |
[328] | |
thioBridge-Glu- (Val-Cit-PAB-MMáE)-PEG (24u) |
CN119072334A+ThioBridge⑪-Glu- (Val-Cit-PAB-MMáE)-PEG (24u)+payload |
Undisclosed |
CN119072334A+ThioBridge⑪-Glu- (Val-Cit-PAB-MMáE)-PEG (24u)+Linker |
[328] | |
thioBridge-Glu-[ (Val-Cit-PAB-MMáE)]2-Glu-[PEG (24u)]2 |
Topo1 inhibitor H |
DNA topoisomerase I (TOP1) |
CN119072334A+ThioBridge⑪-Glu-[ (Val-Cit-PAB-MMáE)]2-Glu-[PEG (24u)]2+Linker |
[328] | |
uS20240148883A1 Compound 18- Target 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 2 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 3 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 4 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 5 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 6 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 7 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 8 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 9 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 18- Target 10 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 2 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 3 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 4 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 5 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 6 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 7 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 8 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 9 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 36- Target 10 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 2 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 3 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 4 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 5 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 6 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 7 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 8 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 9 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
uS20240148883A1 Compound 32- Target 10 |
Undisclosed |
Undisclosed |
Undisclosed |
[329] | |
cN118043080A ADC-4 |
CN118043080A+ADC-4+payload |
Undisclosed |
CN118043080A+ADC-4+Linker |
[330] | |
cN118043080A ADC-5 |
CN118043080A+ADC-5+payload |
Undisclosed |
CN118043080A+ADC-5+Linker |
[330] | |
cN118043080A ADC-6 |
CN118043080A+ADC-6+payload |
Undisclosed |
CN118043080A+ADC-6+Linker |
[330] | |
wO2024099368A1 Tra-CAST-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
WO2024099368A1+Tra-CAST-MMAE+Linker |
[331] | |
cN110845480B ADC1 |
CN110845480B+ADC1+payload |
Undisclosed |
CN110845480B+ADC1+Linker |
[333] | |
cN110845480B ADC2 |
CN110845480B+ADC2+payload |
Undisclosed |
CN110845480B+ADC1+Linker |
[333] | |
cN110845480B ADC3 |
CN110845480B+ADC3+payload |
Undisclosed |
CN110845480B+ADC3+Linker |
[333] | |
cN110845480B ADC4 |
CN110845480B+ADC4+payload |
Undisclosed |
CN110845480B+ADC4+Linker |
[333] | |
jP2024533562A ADC-1 |
JP2024533562A ADC-9 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-2 |
JP2024533562A ADC-10 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-3 |
JP2024533562A ADC-11 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-4 |
EP4494658A1 antibody-drug conjugate 1 payload |
DNA topoisomerase I (TOP1) |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-5 |
JP2024533562A ADC-13 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-6 |
JP2024533562A ADC-14 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-7 |
JP2024533562A ADC-15 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-8 |
JP2024533562A ADC-16 payload |
Undisclosed |
Mc-Val-Cit-PABC |
[335] | |
jP2024533562A ADC-9 |
JP2024533562A ADC-9 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-10 |
JP2024533562A ADC-10 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-11 |
JP2024533562A ADC-11 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-12 |
EP4494658A1 antibody-drug conjugate 1 payload |
DNA topoisomerase I (TOP1) |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-13 |
JP2024533562A ADC-13 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-14 |
JP2024533562A ADC-14 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-15 |
JP2024533562A ADC-15 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-16 |
JP2024533562A ADC-16 payload |
Undisclosed |
JP2024533562A ADC-16 linker |
[335] | |
jP2024533562A ADC-17 |
Undisclosed |
Undisclosed |
Undisclosed |
[335] | |
ab-TfR2-CIDE-BRM1-9 |
Undisclosed |
Undisclosed |
Undisclosed |
||
ab-TfR2-CIDE-BRM1-20 |
Undisclosed |
Undisclosed |
Undisclosed |
||
ab-TfR2-CIDE-BRM1-19 |
Undisclosed |
Undisclosed |
Undisclosed |
||
ab-TfR2-CIDE-BRM1-15 |
Undisclosed |
Undisclosed |
Undisclosed |
||
ab-TfR2-CIDE-BRM1-13 |
Undisclosed |
Undisclosed |
Undisclosed |
||
wO2023173132A1 ADC-12 |
P9 |
Undisclosed |
Undisclosed |
[37] | |
wO2023173132A1 ADC-13 |
P9 |
Undisclosed |
Undisclosed |
[37] | |
wO2023173132A1ADC-14 |
P9 |
Undisclosed |
Undisclosed |
[37] | |
wO2024078586A9 ADC A-01 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-02 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-03 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-04 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-05 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-06 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-07 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-08 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-09 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-10 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-11 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-12 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-13 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-14 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-15 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-16 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-17 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-18 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-19 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-20 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-21 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-22 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-23 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-24 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-25 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC A-26 |
undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-B-01 |
undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-B-02 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-B-03 |
Undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-B-04 |
undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-B-05 |
undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-B-06 |
undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024078586A9 ADC-C-01 |
undisclosed |
Undisclosed |
Undisclosed |
[336] | |
wO2024083953A1 Formula1 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula2 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula3 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula4 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula5 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula6 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula7 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula8 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula9 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula10 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula11 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula12 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula13 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula14 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula15 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
wO2024083953A1 Formula16 |
undisclosed |
Undisclosed |
Undisclosed |
[337] | |
uS11833215B2 5A |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5B |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5C |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5D |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5E |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5F |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5G |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5H |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
uS11833215B2 5I |
Undisclosed |
Undisclosed |
Undisclosed |
[338] | |
iGAC-2 |
IG-L-1 Payload |
Undisclosed |
IG-L-1 linker |
[47] | |
iGAC-4 |
Smol006 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
MP-Ala-Ala-PAB |
[47] | |
iGAC-6 |
IG-L-2 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-8 |
Smol006 |
Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (GSPT1) |
MP-Ala-Ala-PAB |
[47] | |
iGAC-10 |
IG-L-1 Payload |
Undisclosed |
IG-L-1 linker |
[47] | |
iGAC-12 |
IG-L-3 Payload |
Undisclosed |
IG-L-3 linker |
[47] | |
iGAC-14 |
IG-L-7 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-16 |
IG-L-4 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-18 |
IG-L-5 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-20 |
IG-L-9 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-22 |
IG-L-10 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-24 |
IG-L-11 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
iGAC-30 |
IG-L-12 Payload |
Undisclosed |
MP-Ala-Ala-PAB |
[47] | |
jP7560255B2 ControlADC1 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC2 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC3 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC4 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC5 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC59 8 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC7 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC8 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC9 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC10 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC11 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC12 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC13 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC14 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC15 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC16 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC17 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC18 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC19 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC20 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC21 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC22 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC23 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC24 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC25 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC26 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC27 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC28 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC29 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC30 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC31 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC32 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC33 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC34 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC35 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC36 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC37 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC38 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC39 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC40 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC41 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC42 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC43 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC44 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC60 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
jP7560255B2 ControlADC61 |
Undisclosed |
Undisclosed |
Undisclosed |
[339] | |
tW202506738A C-009 |
TW202506738A-C-009-PAYLOAD |
DNA topoisomerase I (TOP1) |
TW202506738A-C-009-LINKER |
[340] | |
tW202506738A C-020 |
TW202506738A-C-009-PAYLOAD |
DNA topoisomerase I (TOP1) |
TW202506738A-C-020-LINKER |
[340] | |
tW202506738A C-025 |
TW202506738A-C-025-PAYLOAD |
Undisclosed |
TW202506738A-C-025-LINKER |
[340] | |
tW202506738A C-027 |
TW202506738A-C-027-PAYLOAD |
Undisclosed |
TW202506738A-C-027-LINKER |
[340] | |
tW202506738A C-031 |
Undisclosed |
Undisclosed |
Undisclosed |
[340] | |
tW202506738A C-037 |
TW202506738A-C-037-PAYLOAD |
Undisclosed |
TW202506738A-C-009-LINKER |
[340] | |
tW202506738A C-038 |
TW202506738A-C-037-PAYLOAD |
Undisclosed |
TW202506738A-C-025-LINKER |
[340] | |
tW202506738A C-039 |
TW202506738A-C-037-PAYLOAD |
Undisclosed |
TW202506738A-C-039-LINKER |
[340] | |
tW202506738A C-043 |
TW202506738A-C-037-PAYLOAD |
Undisclosed |
TW202506738A-C-043-LINKER |
[340] | |
tW202506738A C-046 |
TW202506738A-C-046-PAYLOAD |
Undisclosed |
TW202506738A-C-046-LINKER |
[340] | |
tW202506738A C-052 |
TW202506738A-C-052-PAYLOAD |
Undisclosed |
TW202506738A-C-046-LINKER |
[340] | |
tW202506738A C-056 |
TW202506738A-C-056-PAYLOAD |
Undisclosed |
TW202506738A-C-056-LINKER |
[340] | |
tW202506738A C-059 |
TW202506738A-C-059-PAYLOAD |
Undisclosed |
TW202506738A-C-059-LINKER |
[340] | |
tW202506738A C-063 |
TW202506738A-C-063-PAYLOAD |
Undisclosed |
TW202506738A-C-063-LINKER |
[340] | |
tW202506738A C-066 |
TW202506738A-C-066-PAYLOAD |
Undisclosed |
TW202506738A-C-066-LINKER |
[340] | |
tW202506738A C-071 |
TW202506738A-C-071-PAYLOAD |
Undisclosed |
TW202506738A-C-071-LINKER |
[340] | |
tW202506738A C-079 |
TW202506738A-C-079-PAYLOAD |
Undisclosed |
TW202506738A-C-079-LINKER |
[340] | |
tW202506738A C-084 |
TW202506738A-C-084-PAYLOAD |
Undisclosed |
TW202506738A-C-084-LINKER |
[340] | |
tW202506738A C-087 |
TW202506738A-C-087-PAYLOAD |
Undisclosed |
TW202506738A-C-087-LINKER |
[340] | |
tW202506738A C-093 |
TW202506738A-C-093-PAYLOAD |
Undisclosed |
TW202506738A-C-093-LINKER |
[340] | |
tW202506738A C-096 |
Topo1 inhibitor E |
DNA topoisomerase I (TOP1) |
TW202506738A-C-096-LINKER |
[340] | |
tW202506738A C-102 |
TW202506738A-C-102-PAYLOAD |
Undisclosed |
TW202506738A-C-102-LINKER |
[340] | |
tW202506738A C-109 |
TW202506738A-C-102-PAYLOAD |
Undisclosed |
TW202506738A-C-109-LINKER |
[340] | |
tW202506738A C-111 |
Topo1 inhibitor E |
DNA topoisomerase I (TOP1) |
TW202506738A-C-111-LINKER |
[340] | |
tW202506738A C-118 |
TW202506738A-C-118-PAYLOAD |
Undisclosed |
TW202506738A-C-118-LINKER |
[340] | |
tW202506738A C-123 |
TW202506738A-C-123-PAYLOAD |
Undisclosed |
TW202506738A-C-123-LINKER |
[340] | |
tW202506738A C-133 |
Topo1 inhibitor E |
DNA topoisomerase I (TOP1) |
TW202506738A-C-133-LINKER |
[340] | |
tW202506738A C-155 |
Topo1 inhibitor E |
DNA topoisomerase I (TOP1) |
TW202506738A-C-155-LINKER |
[340] | |
tW202506738A C-168 |
Topo1 inhibitor E |
DNA topoisomerase I (TOP1) |
TW202506738A-C-168-LINKER |
[340] | |
tW202506738A C-172 |
Topo1 inhibitor E |
DNA topoisomerase I (TOP1) |
TW202506738A-C-172-LINKER |
[340] | |
tW202506738A C-182 |
Topo1 inhibitor G |
DNA topoisomerase I (TOP1) |
TW202506738A-C-182-LINKER |
[340] | |
tW202506738A C-186 |
Topo1 inhibitor G |
DNA topoisomerase I (TOP1) |
TW202506738A-C-186-LINKER |
[340] | |
tW202506738A C-208 |
Exatecan |
Undisclosed |
TW202506738A-C-208-LINKER |
[340] | |
tW202506738A C-214 |
TW202506738A-C-214-PAYLOAD |
Undisclosed |
TW202506738A-C-214-LINKER |
[340] | |
tW202506738A C-215 |
TW202506738A-C-215-PAYLOAD |
Undisclosed |
TW202506738A-C-214-LINKER |
[340] | |
tW202506738A C-216 |
TW202506738A-C-216-PAYLOAD |
Undisclosed |
TW202506738A-C-214-LINKER |
[340] | |
tW202506738A C-217 |
TW202506738A-C-216-PAYLOAD |
Undisclosed |
TW202506738A-C-217-LINKER |
[340] | |
tW202506738A C-218 |
TW202506738A-C-218-PAYLOAD |
Undisclosed |
TW202506738A-C-217-LINKER |
[340] | |
tW202506738A C-226 |
TW202506738A-C-226-PAYLOAD |
Undisclosed |
TW202506738A-C-226-LINKER |
[340] | |
tW202506738A C-227 |
TW202506738A-C-227-PAYLOAD |
Undisclosed |
TW202506738A-C-226-LINKER |
[340] | |
tW202506738A C-231 |
TW202506738A-C-231-PAYLOAD |
Undisclosed |
TW202506738A-C-226-LINKER |
[340] | |
tW202506738A C-237 |
Undisclosed |
Undisclosed |
Undisclosed |
[340] | |
tW202506738A C-325 |
TW202506738A-C-325-PAYLOAD |
Undisclosed |
TW202506738A-C-325-LINKER |
[340] | |
tW202506738A C-326 |
TW202506738A-C-326-PAYLOAD |
Undisclosed |
TW202506738A-C-325-LINKER |
[340] | |
tW202506738A C-327 |
TW202506738A-C-327-PAYLOAD |
Undisclosed |
TW202506738A-C-327-LINKER |
[340] | |
tW202506738A C-328 |
TW202506738A-C-327-PAYLOAD |
Undisclosed |
TW202506738A-C-325-LINKER |
[340] | |
tW202506738A C-329 |
TW202506738A-C-329-PAYLOAD |
Undisclosed |
TW202506738A-C-327-LINKER |
[340] | |
tW202506738A C-330 |
TW202506738A-C-330-PAYLOAD |
Undisclosed |
TW202506738A-C-327-LINKER |
[340] | |
tW202506738A C-331 |
TW202506738A-C-331-PAYLOAD |
Undisclosed |
TW202506738A-C-327-LINKER |
[340] | |
tW202506738A C-332 |
TW202506738A-C-332-PAYLOAD |
Microtubule (MT) |
TW202506738A-C-327-LINKER |
[340] | |
tW202506738A C-333 |
TW202506738A-C-332-PAYLOAD |
Microtubule (MT) |
TW202506738A-C-333-LINKER |
[340] | |
tW202506738A C-334 |
TW202506738A-C-332-PAYLOAD |
Microtubule (MT) |
TW202506738A-C-333-LINKER |
[340] | |
tW202506738A C-335 |
TW202506738A-C-332-PAYLOAD |
Microtubule (MT) |
TW202506738A-C-335-LINKER |
[340] | |
tW202506738A C-353 |
TW202506738A-C-353-PAYLOAD |
Undisclosed |
TW202506738A-C-353-LINKER |
[340] | |
tW202506738A C-363 |
TW202506738A-C-363-PAYLOAD |
Undisclosed |
TW202506738A-C-353-LINKER |
[340] | |
tW202506738A C-397 |
TW202506738A-C-397-PAYLOAD |
Undisclosed |
TW202506738A-C-397-LINKER |
[340] | |
tW202506738A C-400 |
TW202506738A-C-400-PAYLOAD |
Undisclosed |
TW202506738A-C-400-LINKER |
[340] | |
cN113318238B ADC-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-3 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-4 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-5 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-6 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-7 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-8 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-9 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN113318238B ADC-10 |
Undisclosed |
Undisclosed |
Undisclosed |
[341] | |
cN119630431A ADC-82 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-83 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-84 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-83-LINKER |
[5] | |
cN119630431A ADC-85 |
CN119630431A-ADC-84-PAYLOAD |
Undisclosed |
CN119630431A-ADC-67-LINKER |
[5] | |
cN119630431A ADC-86 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-87 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-88 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-83-LINKER |
[5] | |
cN119630431A ADC-89 |
CN119630431A-ADC-84-PAYLOAD |
Undisclosed |
CN119630431A-ADC-67-LINKER |
[5] | |
cN119630431A ADC-93 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-95 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-96 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-97 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
cN119630431A ADC-98 |
CN119630431A-ADC-82-PAYLOAD |
Undisclosed |
CN119630431A-ADC-82-LINKER |
[5] | |
mK-6204 |
Undisclosed |
Undisclosed |
Undisclosed |
||
sLV-154 |
Undisclosed |
Undisclosed |
Undisclosed |
||
aBBV-324 |
Undisclosed |
Undisclosed |
Undisclosed |
||
mHB046C |
TOP1 inhibitor |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
||
sLV-324 |
Undisclosed |
Undisclosed |
Undisclosed |
||
pHN-012 |
Undisclosed |
Undisclosed |
Undisclosed |
||
mBRC-201 |
Undisclosed |
Undisclosed |
Undisclosed |
||
wEF-001 |
Monomethyl auristatin E |
Microtubule (MT) |
Undisclosed |
||
fS001 |
TOP1 inhibitor |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
||
bL-M24D1 |
WA-00 |
Microtubule (MT) |
Undisclosed |
||
oNA-255 |
Undisclosed |
Undisclosed |
Undisclosed |
||
aBBV-901 |
Undisclosed |
Undisclosed |
Undisclosed |
||
aDCE-B05 |
Undisclosed |
Undisclosed |
Undisclosed |
||
aK0406 |
Undisclosed |
Undisclosed |
Undisclosed |
||
tORL-5-700 |
Undisclosed |
Undisclosed |
Undisclosed |
||
mG2002A |
Undisclosed |
Undisclosed |
Undisclosed |
||
mG2001 |
Undisclosed |
Undisclosed |
Undisclosed |
||
mG1901 |
Undisclosed |
Undisclosed |
Undisclosed |
||
tarcocimab tedromer |
Undisclosed |
Undisclosed |
Undisclosed |
||
kSI-501 |
Undisclosed |
Undisclosed |
Undisclosed |
||
aDCX-020 |
TOP1 inhibitor |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Undisclosed
| ADC Info | ADC Name | Payload | Target | Linker | Ref |
|---|---|---|---|---|---|
CPO-204 |
Undisclosed |
Undisclosed |
Undisclosed |
||
MG-1901 |
Undisclosed |
Undisclosed |
Undisclosed |
||
MG-2001 |
Undisclosed |
Undisclosed |
Undisclosed |
||
MG-2002A |
Undisclosed |
Undisclosed |
Undisclosed |
||
131I-ImmuRAIT-HCG |
Undisclosed |
Undisclosed |
Undisclosed |
[54] | |
NBT-588 |
Undisclosed |
Undisclosed |
Undisclosed |
[55] | |
NBT-588 |
Undisclosed |
Undisclosed |
Undisclosed |
[55] | |
RC-168 |
Undisclosed |
Undisclosed |
Undisclosed |
[56] | |
RC-178 |
Undisclosed |
Undisclosed |
Undisclosed |
[56] | |
RC-188 |
Undisclosed |
Undisclosed |
Undisclosed |
[56] | |
XNW-28012 |
Undisclosed |
Undisclosed |
Undisclosed |
[57] | |
Bi-specific antibody drug conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[58] | |
ZV03-ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[59] | |
AR081 |
Undisclosed |
Undisclosed |
Undisclosed |
[60] | |
BC5084 |
Undisclosed |
Undisclosed |
Undisclosed |
[61] | |
WTX-116 |
Undisclosed |
Undisclosed |
Undisclosed |
[62] | |
WTX-231 |
Undisclosed |
Undisclosed |
Undisclosed |
[62] | |
WTX-222 |
Undisclosed |
Undisclosed |
Undisclosed |
[62] | |
VIS-705 |
Undisclosed |
Undisclosed |
Undisclosed |
[63] | |
Second ADC (Virtuoso Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[64] | |
LEAD ADC (Virtuoso Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[65] | |
Additional antibody drug conjugate (Virtuoso Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[66] | |
VLS-301 |
Undisclosed |
Undisclosed |
Undisclosed |
[67] | |
VLS-201 |
Undisclosed |
Undisclosed |
Undisclosed |
[68] | |
Vas-202 |
Undisclosed |
Undisclosed |
Undisclosed |
[69] | |
Vas-201 |
Undisclosed |
Undisclosed |
Undisclosed |
[70] | |
Anticancer antibody-drug conjugate (Vaccinex/Catalent Pharma Solutions) |
Undisclosed |
Undisclosed |
Undisclosed |
[71] | |
TUB-060 |
Undisclosed |
Undisclosed |
Undisclosed |
[72] | |
TUB-050 |
Undisclosed |
Undisclosed |
Undisclosed |
[72] | |
TAE-020 |
Undisclosed |
Undisclosed |
Undisclosed |
[73] | |
TT-01 |
Undisclosed |
Undisclosed |
Undisclosed |
[74] | |
TGM-005 |
Undisclosed |
Undisclosed |
Undisclosed |
[75] | |
TGM-004 |
Undisclosed |
Undisclosed |
Undisclosed |
[76] | |
TGM-003 |
Undisclosed |
Undisclosed |
Undisclosed |
[77] | |
TGM-002 |
Undisclosed |
Undisclosed |
Undisclosed |
[78] | |
Antibody boron conjugate radiopharmaceuticals (TAE Life Sciences) |
Undisclosed |
Undisclosed |
Undisclosed |
[79] | |
SIM-005A |
Undisclosed |
Undisclosed |
Undisclosed |
[80] | |
SIM-002A |
Undisclosed |
Undisclosed |
Undisclosed |
[81] | |
SIB-004A |
Undisclosed |
Undisclosed |
Undisclosed |
[82] | |
BL-B029A1 |
Undisclosed |
Undisclosed |
Undisclosed |
[83] | |
BL-M002A2 |
Undisclosed |
Undisclosed |
Undisclosed |
[84] | |
Antibody-drug conjugate 4 (Synthon) |
Undisclosed |
Undisclosed |
Undisclosed |
[85] | |
Antibody-drug conjugate 3 (Synthon) |
Undisclosed |
Undisclosed |
Undisclosed |
[86] | |
SAB-Y17 |
Undisclosed |
Undisclosed |
Undisclosed |
[87] | |
SAB-Y1 |
Undisclosed |
Undisclosed |
Undisclosed |
[87] | |
SDV-1001 |
Undisclosed |
Undisclosed |
Undisclosed |
[88] | |
Antibody-drug conjugate (SynAffix) |
Undisclosed |
Undisclosed |
Undisclosed |
[89] | |
ADC project 7 (Suzhou Medilink Therapeutics Ltd.) |
Undisclosed |
Undisclosed |
Undisclosed |
[90] | |
ADC project 6 (Suzhou Medilink Therapeutics Ltd.) |
Undisclosed |
Undisclosed |
Undisclosed |
[90] | |
ADC project 5 (Suzhou Medilink Therapeutics Ltd.) |
Undisclosed |
Undisclosed |
Undisclosed |
[90] | |
ADC project 4 (Suzhou Medilink Therapeutics Ltd.) |
Undisclosed |
Undisclosed |
Undisclosed |
[90] | |
BsAb-ADC (Medilink Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[91] | |
SOT106 |
Undisclosed |
Undisclosed |
Undisclosed |
[92] | |
SMD-5033 |
Undisclosed |
Undisclosed |
Undisclosed |
[93] | |
SMD-3117 |
Undisclosed |
Undisclosed |
Undisclosed |
[94] | |
HY-0001 |
Undisclosed |
Undisclosed |
Undisclosed |
[95] | |
BL-M005 |
Undisclosed |
Undisclosed |
Undisclosed |
[96] | |
BL-M22D1 |
Undisclosed |
Undisclosed |
Undisclosed |
[97] | |
P-BsAb-ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[98] | |
JY210 |
Undisclosed |
Undisclosed |
Undisclosed |
[99] | |
JY208 |
Undisclosed |
Undisclosed |
Undisclosed |
[99] | |
SY-1558 |
Undisclosed |
Undisclosed |
Undisclosed |
[100] | |
MRG-006 |
Undisclosed |
Undisclosed |
Undisclosed |
[101] | |
MRX-23 |
Undisclosed |
Undisclosed |
Undisclosed |
[102] | |
MG2106E |
Undisclosed |
Undisclosed |
Undisclosed |
[103] | |
MG2018 |
Undisclosed |
Undisclosed |
Undisclosed |
[103] | |
MG2011C |
Undisclosed |
Undisclosed |
Undisclosed |
[103] | |
MG2002B |
Undisclosed |
Undisclosed |
Undisclosed |
[103] | |
Antibody-drug conjugate (Sanofi/Seagen) |
Undisclosed |
Undisclosed |
Undisclosed |
[104] | |
SGN-25 |
Undisclosed |
Undisclosed |
Undisclosed |
[105] | |
APEC-3 |
Undisclosed |
Undisclosed |
Undisclosed |
[106] | |
APEC-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[107] | |
RAD-501 |
Undisclosed |
Undisclosed |
Undisclosed |
[108] | |
PLBC-003 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBC-002 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBC-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBA-005 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBA-004 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBA-003 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBA-002 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PLBA-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[109] | |
PSM-101 |
Undisclosed |
Undisclosed |
Undisclosed |
[110] | |
DN-028 |
Undisclosed |
Undisclosed |
Undisclosed |
[111] | |
DN-027 |
Undisclosed |
Undisclosed |
Undisclosed |
[112] | |
PHN-020 |
Undisclosed |
Undisclosed |
Undisclosed |
[113] | |
Antibody-drug conjugate containing OXS-2175 (Oxis Biotech/MultiCell ImmunoTherapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[114] | |
OX-004 |
Undisclosed |
Undisclosed |
Undisclosed |
[115] | |
Antibody-drug conjugate (Oxford BioTherapeutics/Boehringer Ingelheim) |
Undisclosed |
Undisclosed |
Undisclosed |
[116] | |
OBT542 |
Undisclosed |
Undisclosed |
Undisclosed |
[117] | |
OBT207 |
Undisclosed |
Undisclosed |
Undisclosed |
[117] | |
OBT029 |
Undisclosed |
Undisclosed |
Undisclosed |
[117] | |
Next generation antibody-drug conjugate (Oxford BioTherapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[118] | |
NBT-598 |
Undisclosed |
Undisclosed |
Undisclosed |
[119] | |
NBT-578 |
Undisclosed |
Undisclosed |
Undisclosed |
[120] | |
NBT-568 |
Undisclosed |
Undisclosed |
Undisclosed |
[121] | |
NBT-528 |
Undisclosed |
Undisclosed |
Undisclosed |
[122] | |
NW-12-005 |
Undisclosed |
Undisclosed |
Undisclosed |
[123] | |
NTX-1107 |
Undisclosed |
Undisclosed |
Undisclosed |
[124] | |
SO-N107 |
Undisclosed |
Undisclosed |
Undisclosed |
[125] | |
NBE-003 |
Undisclosed |
Undisclosed |
Undisclosed |
[126] | |
NBE-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[127] | |
MBC-301 |
Undisclosed |
Undisclosed |
Undisclosed |
[128] | |
G-100 (Magenta Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[129] | |
MBK-101 |
Undisclosed |
Undisclosed |
Undisclosed |
[130] | |
LCB-69 |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-91 |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-09A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-42A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-20A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-19A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-18A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB14-15nm |
Undisclosed |
Undisclosed |
Undisclosed |
[132] | |
LCB-12A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-06A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-04A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-02A |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LCB-88 |
Undisclosed |
Undisclosed |
Undisclosed |
[133] | |
LCB-85 |
Undisclosed |
Undisclosed |
Undisclosed |
[131] | |
LP-A18 |
Undisclosed |
Undisclosed |
Undisclosed |
[134] | |
LM-007 |
Undisclosed |
Undisclosed |
Undisclosed |
[135] | |
LM-006 |
Undisclosed |
Undisclosed |
Undisclosed |
[135] | |
LM-005 |
Undisclosed |
Undisclosed |
Undisclosed |
[135] | |
LM-004 |
Undisclosed |
Undisclosed |
Undisclosed |
[135] | |
LM-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[135] | |
LM-317 |
Undisclosed |
Undisclosed |
Undisclosed |
[136] | |
LM-008 |
Undisclosed |
Undisclosed |
Undisclosed |
[135] | |
KGX201 |
Undisclosed |
Undisclosed |
Undisclosed |
[137] | |
IOG-101 |
Undisclosed |
Undisclosed |
Undisclosed |
[138] | |
DBAF-301 |
Undisclosed |
Undisclosed |
Undisclosed |
[139] | |
IN30718 |
Undisclosed |
Undisclosed |
Undisclosed |
[140] | |
IMB-213I |
Undisclosed |
Undisclosed |
Undisclosed |
[141] | |
IMB-212 |
Undisclosed |
Undisclosed |
Undisclosed |
[141] | |
IKS-02 |
Undisclosed |
Undisclosed |
Undisclosed |
[142] | |
IKS-04 |
Undisclosed |
Undisclosed |
Undisclosed |
[142] | |
Glaucoma therapy |
Undisclosed |
Undisclosed |
Undisclosed |
[143] | |
HDP-104 |
Undisclosed |
Undisclosed |
Undisclosed |
[144] | |
DXC-020 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-019 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-018 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-017 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-016 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-015 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-013 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-012 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-011 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
DXC-010 |
Undisclosed |
Undisclosed |
Undisclosed |
[145] | |
Monoclonal Antibody-Drug Conjugate (Kind Pharmaceuticals) |
Undisclosed |
Undisclosed |
Undisclosed |
[146] | |
GBM-12401 |
Undisclosed |
Undisclosed |
Undisclosed |
[147] | |
GMA-305 |
Undisclosed |
Undisclosed |
Undisclosed |
[148] | |
GMA-205 |
Undisclosed |
Undisclosed |
Undisclosed |
[149] | |
SeeloMab-GEX |
Undisclosed |
Undisclosed |
Undisclosed |
[150] | |
P-1000 |
Undisclosed |
Undisclosed |
Undisclosed |
[151] | |
GL-231 |
Undisclosed |
Undisclosed |
Undisclosed |
[152] | |
GF-2014 |
Undisclosed |
Undisclosed |
Undisclosed |
[153] | |
GR1018 |
Undisclosed |
Undisclosed |
Undisclosed |
[154] | |
GR-1016 |
Undisclosed |
Undisclosed |
Undisclosed |
[154] | |
GR-1015 |
Undisclosed |
Undisclosed |
Undisclosed |
[154] | |
GR-1014 |
Undisclosed |
Undisclosed |
Undisclosed |
[154] | |
GQ-1009 |
Undisclosed |
Undisclosed |
Undisclosed |
[154] | |
M-131 |
Undisclosed |
Undisclosed |
Undisclosed |
[155] | |
EVOLVE-104 ADC |
Undisclosed |
Undisclosed |
Undisclosed |
[156] | |
EP-400 |
Undisclosed |
Undisclosed |
Undisclosed |
[157] | |
PCG-N003 |
Undisclosed |
Undisclosed |
Undisclosed |
[158] | |
PCG-C006 |
Undisclosed |
Undisclosed |
Undisclosed |
[158] | |
PCG-C004 |
Undisclosed |
Undisclosed |
Undisclosed |
[158] | |
PCG-C002 |
Undisclosed |
Undisclosed |
Undisclosed |
[158] | |
DOM-1314 |
Undisclosed |
Undisclosed |
Undisclosed |
[159] | |
AccuADC-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[160] | |
CM-09 |
Undisclosed |
Undisclosed |
Undisclosed |
[161] | |
CS-5002 |
Undisclosed |
Undisclosed |
Undisclosed |
[162] | |
CBP-1609 |
Undisclosed |
Undisclosed |
Undisclosed |
[163] | |
Antiviral Fc-conjugate (Cidara Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[164] | |
CRB-2107 |
Undisclosed |
Undisclosed |
Undisclosed |
[165] | |
Monoclonal Antibody-Drug conjugate (Celltrion Chemical Research Institute/Immunogen/Celltrion) |
Undisclosed |
Undisclosed |
Undisclosed |
[166] | |
CT-P26 |
Undisclosed |
Undisclosed |
Undisclosed |
[167] | |
CAT-03-106 |
Undisclosed |
Undisclosed |
Undisclosed |
[168] | |
BMT-125961 |
Undisclosed |
Undisclosed |
Undisclosed |
[169] | |
BRKB-28 |
Undisclosed |
Undisclosed |
Undisclosed |
[170] | |
BIO104 |
Undisclosed |
Undisclosed |
Undisclosed |
[171] | |
BIO103 |
Undisclosed |
Undisclosed |
Undisclosed |
[171] | |
LD016 |
Undisclosed |
Undisclosed |
Undisclosed |
[172] | |
BSC-4201 |
Undisclosed |
Undisclosed |
Undisclosed |
[173] | |
BSC-4101 |
Undisclosed |
Undisclosed |
Undisclosed |
[174] | |
BSI-023 |
Undisclosed |
Undisclosed |
Undisclosed |
[175] | |
BIOO-4 |
Undisclosed |
Undisclosed |
Undisclosed |
[176] | |
BIOO-3 |
Undisclosed |
Undisclosed |
Undisclosed |
[177] | |
BIOO-2 |
Undisclosed |
Undisclosed |
Undisclosed |
[178] | |
BIOO-1 |
Undisclosed |
Undisclosed |
Undisclosed |
[179] | |
BIO-201 |
Undisclosed |
Undisclosed |
Undisclosed |
[180] | |
BIO-108 |
Undisclosed |
Undisclosed |
Undisclosed |
[180] | |
BIO-107 |
Undisclosed |
Undisclosed |
Undisclosed |
[180] | |
BIO-110 |
Undisclosed |
Undisclosed |
Undisclosed |
[180] | |
BIO-109 |
Undisclosed |
Undisclosed |
Undisclosed |
[180] | |
Advanced antibody drug conjugate (Belrose Pharma) |
Undisclosed |
Undisclosed |
Undisclosed |
[181] | |
NX-08 |
Undisclosed |
Undisclosed |
Undisclosed |
[182] | |
JY-023 |
Undisclosed |
Undisclosed |
Undisclosed |
[183] | |
AT-01 |
Undisclosed |
Undisclosed |
Undisclosed |
[184] | |
AT-00 |
Undisclosed |
Undisclosed |
Undisclosed |
[185] | |
AT-04 |
Undisclosed |
Undisclosed |
Undisclosed |
[184] | |
AVP20 |
Undisclosed |
Undisclosed |
Undisclosed |
[186] | |
Antibody drug conjugate containing duocarmycin analogue |
Undisclosed |
Undisclosed |
Undisclosed |
[187] | |
Antibody drug conjugate (Halozyme) |
Undisclosed |
Undisclosed |
Undisclosed |
[188] | |
APB-CS |
Undisclosed |
Undisclosed |
Undisclosed |
[189] | |
Monoclonal Antibody-Drug Conjugate (Antengene) |
Undisclosed |
Undisclosed |
Undisclosed |
[190] | |
ANG-101 |
Undisclosed |
Undisclosed |
Undisclosed |
[191] | |
Anti-cancer therapeutic (Amgen) |
Undisclosed |
Undisclosed |
Undisclosed |
[192] | |
AK 30 NGF |
Undisclosed |
Undisclosed |
Undisclosed |
[193] | |
AMB-015 |
Undisclosed |
Undisclosed |
Undisclosed |
[194] | |
ADRX-863 |
Undisclosed |
Undisclosed |
Undisclosed |
[195] | |
AbGn-108 |
Undisclosed |
Undisclosed |
Undisclosed |
[196] | |
BIO-112 |
Undisclosed |
Undisclosed |
Undisclosed |
[180] | |
STING based antibody-drug conjugate (Exelixis) |
STING agonist |
Stimulator of interferon genes protein (STING1) |
Undisclosed |
[197] | |
BL-M005A2 |
Dual-warhead |
Undisclosed |
Undisclosed |
[198] | |
SMP-190 |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Unique hydrophilic Linker |
[199] | |
CBX-13 |
Mertansine DM4 |
Microtubule (MT) |
Undisclosed |
[200] | |
PTM-001-ADC |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[201] | |
APH-0912 |
Docetaxel |
Microtubule (MT) |
Hydrophilic linker containing sugar molecules |
[202] | |
Dual-payload ADC (Mersana Therapeutics) |
AF-HPA+DNA monoalkylator I-BiP |
Ribosome (RB); Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
[203] | |
TAK-ATACs |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Undisclosed |
[204] | |
Antibody targeted amanitin conjugate |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Undisclosed |
[205] | |
Alpha-amanitin antibody-drug conjugate (Agensys) |
Alpha-amanitin |
DNA-directed RNA polymerase II subunit RPB2 (POLR2B); DNA-directed RNA polymerase III subunit RPC7 (POLR3G) |
Undisclosed |
[206] | |
Eribulin ADC (Jiangsu hengrui) |
Eribulin |
Microtubule (MT) |
Undisclosed |
[207] | |
CBX-14 |
Multi-targetd DDR inhibitor |
Epithelial discoidin domain-containing receptor 1 (DDR1) |
Undisclosed |
[200] | |
Masked ADC (Adagene/ADC Therapeutics) |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
[208] | |
Spliceostatin-antibody-drug conjugate |
Spliceostatin A |
Splicing factor 3B subunit 1 (SF3B1) |
Undisclosed |
[209] | |
XMT-2175 |
STING agonist |
Stimulator of interferon genes protein (STING1) |
Undisclosed |
[210] | |
XMT-2068 |
STING agonist |
Stimulator of interferon genes protein (STING1) |
Undisclosed |
[210] | |
STING agonist ADC |
STING agonist |
Stimulator of interferon genes protein (STING1) |
Undisclosed |
[211] | |
EX108 |
Undisclosed |
Undisclosed |
Undisclosed |
[212] | |
ADC2313 |
Undisclosed |
Undisclosed |
Undisclosed |
[213] | |
ADC2154 |
Undisclosed |
Undisclosed |
Undisclosed |
[214] | |
ADC2231 |
Undisclosed |
Undisclosed |
Undisclosed |
[215] | |
ADC2335 |
Undisclosed |
Undisclosed |
Undisclosed |
[216] | |
ADC2317 |
Undisclosed |
Undisclosed |
Undisclosed |
[217] | |
BR-2202 |
Undisclosed |
Undisclosed |
Undisclosed |
[218] | |
BR-2102 |
Undisclosed |
Undisclosed |
Undisclosed |
[218] | |
BR-2003 |
Undisclosed |
Undisclosed |
Undisclosed |
[218] | |
BB-1708 |
Undisclosed |
Undisclosed |
Undisclosed |
[218] | |
BB-1706 |
Undisclosed |
Undisclosed |
Undisclosed |
[218] | |
BB-1710 |
Undisclosed |
Undisclosed |
Undisclosed |
[218] | |
MABS-01 |
Undisclosed |
Undisclosed |
Undisclosed |
[219] | |
MABS-02 |
Undisclosed |
Undisclosed |
Undisclosed |
[219] | |
PBX-002 |
Undisclosed |
Undisclosed |
Undisclosed |
[220] | |
SY-1700 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
SY-1274 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
SY-0831 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
SY-1330 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
SY-0833 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
SY-1211 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
SY-0625 |
Undisclosed |
Undisclosed |
Undisclosed |
[221] | |
BRKB-44 |
Undisclosed |
Undisclosed |
Undisclosed |
[222] | |
AMB-101 |
Topoisomerase I inhibitor |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[223] | |
AMB-102 |
Undisclosed |
Undisclosed |
Undisclosed |
[224] | |
BP-A102 |
Undisclosed |
Undisclosed |
Undisclosed |
[225] | |
BP-A103 |
Undisclosed |
Undisclosed |
Undisclosed |
[225] | |
AU-011 |
IRDye 700DX |
Undisclosed |
Undisclosed |
[226] | |
IMB-202 |
Undisclosed |
Undisclosed |
Undisclosed |
[227] | |
3-NAntC |
Undisclosed |
Undisclosed |
Undisclosed |
[228] | |
BIO105 |
Undisclosed |
Undisclosed |
Undisclosed |
[229] | |
CO-1003 |
Undisclosed |
Undisclosed |
Undisclosed |
[230] | |
CO-1023 |
Undisclosed |
Undisclosed |
Undisclosed |
[230] | |
BR107 |
Undisclosed |
Undisclosed |
Undisclosed |
[231] | |
BR109 |
Undisclosed |
Undisclosed |
Undisclosed |
[232] | |
BRY811 |
Undisclosed |
Undisclosed |
Undisclosed |
[233] | |
OTV:CH2 |
Undisclosed |
Undisclosed |
Undisclosed |
[234] | |
OTV:LF3 |
Undisclosed |
Undisclosed |
Undisclosed |
[234] | |
IN30728 |
Undisclosed |
Undisclosed |
Undisclosed |
[235] | |
NW-001 |
Undisclosed |
Undisclosed |
Undisclosed |
[236] | |
FG-B310 |
Undisclosed |
Undisclosed |
Undisclosed |
[237] | |
FG-M131 |
Undisclosed |
Undisclosed |
Undisclosed |
[237] | |
ADC001 (Arbele) |
Undisclosed |
Undisclosed |
Undisclosed |
[238] | |
ADC002 (Arbele) |
Undisclosed |
Undisclosed |
Undisclosed |
[238] | |
ADC003 (Arbele) |
Undisclosed |
Undisclosed |
Undisclosed |
[238] | |
TST013 |
Undisclosed |
Undisclosed |
Undisclosed |
[239] | |
CS5005 |
Undisclosed |
Undisclosed |
Undisclosed |
[240] | |
CS5006 |
Undisclosed |
Undisclosed |
Undisclosed |
[240] | |
Monovalent Azymatic Antibody Drug Conjugate (Zymeworks) |
Undisclosed |
Undisclosed |
Undisclosed |
[241] | |
Antibody-drug conjugate (University of Toronto/ImmunoBiochem) |
Undisclosed |
Undisclosed |
Undisclosed |
[242] | |
Antibody-drug conjugate (University of Toronto/Advanced Proteome Therapeutics) |
Undisclosed |
Undisclosed |
Undisclosed |
[243] | |
Multi-functional antibody drug conjugate combination therapeutics (Sutro Biopharma/Celgene) |
Undisclosed |
Undisclosed |
Undisclosed |
[244] | |
MRG-009 |
Undisclosed |
Undisclosed |
Undisclosed |
[245] | |
MRG-008 |
Undisclosed |
Undisclosed |
Undisclosed |
[246] | |
MRG-007 |
Undisclosed |
Undisclosed |
Undisclosed |
[247] | |
MRG-005 |
Undisclosed |
Undisclosed |
Undisclosed |
[248] | |
LCB14-2nm |
Undisclosed |
Undisclosed |
Undisclosed |
[249] | |
CYP-Ab |
Undisclosed |
Undisclosed |
Undisclosed |
[250] | |
Antibody drug conjugate (Sanofi) |
Undisclosed |
Undisclosed |
Undisclosed |
[251] | |
Antibody drug conjugate (Compugen) |
Undisclosed |
Undisclosed |
Undisclosed |
[252] | |
Antibody-drug conjugate therapy (Neoantigenics) |
Undisclosed |
Undisclosed |
Undisclosed |
[253] | |
Antibody drug conjugate (Meditope Biosciences) |
Undisclosed |
Undisclosed |
Undisclosed |
[254] | |
LIN-003 |
Undisclosed |
Undisclosed |
Undisclosed |
[255] | |
KSI-201 |
Undisclosed |
Undisclosed |
Undisclosed |
[256] | |
Antibody drug conjugate (Intrexon) |
Undisclosed |
Undisclosed |
Undisclosed |
[257] | |
CRC-02 targeting antibody-drug conjugate |
Undisclosed |
Undisclosed |
Undisclosed |
[258] | |
Antibody-drug conjugate (Daiichi Sankyo) |
Undisclosed |
Undisclosed |
Undisclosed |
[259] | |
Antibody drug conjugate (Asana BioSciences) |
Undisclosed |
Undisclosed |
Undisclosed |
[260] | |
BIOO-7 |
Undisclosed |
Undisclosed |
Undisclosed |
[261] | |
BIOO-6 |
Undisclosed |
Undisclosed |
Undisclosed |
[262] | |
BIOO-5 |
Undisclosed |
Undisclosed |
Undisclosed |
[263] | |
Antibody-drug conjugate (Bristol-Myers Squibb) |
Undisclosed |
Undisclosed |
Undisclosed |
[264] | |
Marine-derived cytotoxic payloads antibody-drug conjugation |
Undisclosed |
Undisclosed |
Undisclosed |
[265] | |
Antibody drug conjugate (Five Prime cancer) |
Undisclosed |
Undisclosed |
Undisclosed |
[266] | |
CBX-12 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
Undisclosed |
[267] | |
DAN-222 |
Undisclosed |
Undisclosed |
Undisclosed |
[268] | |
CHB-111 |
Undisclosed |
Undisclosed |
Undisclosed |
[269] | |
RG-7986 |
Undisclosed |
Undisclosed |
Undisclosed |
[270] | |
DS001 |
Undisclosed |
Undisclosed |
Undisclosed |
[271] | |
mAb2-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb3-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb4-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb5-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb6-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb7-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb8-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb9-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb10-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb11-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb12-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb13-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb14-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb15-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb16-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb17-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb18-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb2-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb3-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb17-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[321] | |
mAb2-DXd |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[321] | |
mAb3-DXd |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[321] | |
mAb17-DXd |
DX-8951 derivative (DXd) |
DNA topoisomerase 1 (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[321] | |
mAb2-MMAF+MMAE 1 |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb1-MMAF+GGFG-DXd |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb1-MMAF+CL2A-SN38 |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb2-MMAE+MMAF |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb2-MMAE+GGFG-DXd |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb2-MMAE+CL2A-SN38 |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb2-MMAF+MMAE 2 |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb2-MMAF+CL2A-SN38 |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
mAb3-MMAE+DXd |
Undisclosed |
Undisclosed |
Undisclosed |
[321] | |
isumab04-C5 |
compound 5 |
DNA topoisomerase I (TOP1) |
Undisclosed |
[322] | |
isumab04-C6 |
WO2025015586A1, ADC24, Payload |
Toll-like receptor 7 (TLR7); Toll-like receptor 8 (TLR8) |
Undisclosed |
[322] | |
diS-Compound -145 |
FD6 |
DNA topoisomerase I (TOP1) |
TW202426058A+DiS-Compound -145+Linker |
[323] | |
mC-VA-Compound140 |
TW202426058A+MC-VA-Compound140+payload |
Undisclosed |
Mc-Val-Ala |
[323] | |
nHC-C-VA-Compound140 |
10NH2-11F-Camptothecin |
DNA topoisomerase I (TOP1) |
TW202426058A+NHC-C--VA-Compound140+Linker |
[323] | |
cN115160403A B1 |
CN115160403A+B1+payload |
DNA topoisomerase I (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B2 |
CN115160403A+B2+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B3 |
CN115160403A+B3+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B4 |
CN115160403A+B4+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B5 |
CN115160403A+B5+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B6 |
CN115160403A+B6+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B7 |
CN115160403A+B7+payload |
DNA topoisomerase I (TOP1) |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B8 |
CN115160403A+B8+payload |
Undisclosed |
Mc-Gly-Gly-Phe-Gly |
[326] | |
cN115160403A B9 |
CN115160403A+B9+payload |
Undisclosed |
CN115160403A+B9+Linker |
[326] | |
cN115160403A B10 |
CN115160403A+B9+payload |
Undisclosed |
CN115160403A+B10+Linker |
[326] | |
cN115160403A B11 |
CN115160403A+B9+payload |
Undisclosed |
CN115160403A+B11+Linker |
[326] | |
cN115160403A B12 |
CN115160403A+B9+payload |
Undisclosed |
CN115160403A+B12+Linker |
[326] | |
cN115160403A B13 |
(4-NH2)-Exatecan |
DNA topoisomerase I (TOP1) |
CN115160403A+B11+Linker |
[326] | |
cN115160403A B14 |
CN115160403A+B1+payload |
DNA topoisomerase I (TOP1) |
CN115160403A+B14+Linker |
[326] | |
cN115160403A B15 |
CN115160403A+B1+payload |
DNA topoisomerase I (TOP1) |
CN115160403A+B15+Linker |
[326] | |
cN115160403A B16 |
CN115160403A+B7+payload |
DNA topoisomerase I (TOP1) |
CN115160403A+B11+Linker |
[326] | |
cN115160403A B17 |
CN115160403A+B7+payload |
DNA topoisomerase I (TOP1) |
CN115160403A+B17+Linker |
[326] | |
cN115160403A B18 |
CN115160403A+B7+payload |
DNA topoisomerase I (TOP1) |
CN115160403A+B18+Linker |
[326] | |
cN115160403A B19 |
CN115160403A+B19+payload |
Undisclosed |
CN115160403A+B19+Linker |
[326] | |
cN115160403A B20 |
CN115160403A+B20+payload |
Undisclosed |
CN115160403A+B20+Linker |
[326] | |
cN115160403A B21 |
CN115160403A+B20+payload |
Undisclosed |
CN115160403A+B19+Linker |
[326] | |
cN115160403A B22 |
CN115160403A+B20+payload |
Undisclosed |
CN115160403A+B22+Linker |
[326] | |
cN115160403A B23 |
CN115160403A+B19+payload |
Undisclosed |
CN115160403A+B22+Linker |
[326] | |
cN115160403A B24 |
CN115160403A+B19+payload |
Undisclosed |
CN115160403A+B24+Linker |
[326] | |
cN115160403A B25 |
CN115160403A+B20+payload |
Undisclosed |
CN115160403A+B24+Linker |
[326] | |
igG2a-Val-Cit-Pab-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
WO2024102603A1+lgG2a-Val-Cit-Pab-MMAE+Linker |
[332] | |
wO2024118785A3 Lot22 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot23 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot24 |
P9 |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot34 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot36 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot38 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot49 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot50 |
P9 |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot57 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot61 |
P9 |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot62 |
P9 |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot70 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot71 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot77 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot78 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot79 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot80 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] | |
wO2024118785A3 Lot91 |
Undisclosed |
Undisclosed |
Undisclosed |
[334] |
References
